data_2mw6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mw6 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.3 mp . . . . . 0 CA--C 1.545 0.784 0 CA-C-O 118.673 -0.679 . . . . 1.8200000000000001 112.306 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.28 -12.07 31.25 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.275 1.983 . . . . 1.0800000000000001 113.779 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' HD1' ' A' ' 19' ' ' TRP . . . -72.72 -40.73 65.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.457 0.303 . . . . 0.92000000000000004 111.472 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.43 -34.82 68.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.173 -0.467 . . . . 1.8100000000000001 110.908 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -69.91 -35.77 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.793 -0.64 . . . . 1.4199999999999999 109.99 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.4 m -74.62 -30.39 61.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.659 -0.7 . . . . 1.1000000000000001 111.251 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.409 ' HD1' ' O ' ' A' ' 15' ' ' ALA . 15.1 m95 -74.6 -37.81 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.286 -0.416 . . . . 1.52 111.23 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 pp -76.03 -30.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 116.341 -0.39 . . . . 1.7 111.134 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -76.36 -32.57 58.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.011 -0.54 . . . . 2.1000000000000001 111.058 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.9 mtt180 -80.97 -26.38 36.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.174 -0.467 . . . . 2.3399999999999999 111.096 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.26 -23.87 28.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.094 -0.503 . . . . 1.8500000000000001 111.232 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.1 ttt180 -91.06 -31.26 16.34 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.534 0.521 . . . . 2.0099999999999998 111.304 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.39 -44.44 9.65 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.257 0.348 . . . . 1.53 111.358 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 53.5 mt-30 . . . . . 0 N--CA 1.466 0.359 0 O-C-N 123.396 0.435 . . . . 1.3100000000000001 111.075 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 118.7 -0.667 . . . . 1.8200000000000001 111.647 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.98 -5.62 14.64 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.395 2.064 . . . . 1.0800000000000001 113.325 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.61 67.94 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 122.712 0.405 . . . . 0.92000000000000004 111.911 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tp -72.76 -35.42 67.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 1.8100000000000001 110.951 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mm -71.01 -36.7 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.856 -0.611 . . . . 1.4199999999999999 110.14 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -74.6 -29.81 61.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.85 -0.614 . . . . 1.1000000000000001 111.388 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -75.75 -36.91 59.74 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.421 0.45 . . . . 1.52 111.204 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -76.31 -31.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.301 -0.409 . . . . 1.7 110.947 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -75.96 -34.16 59.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.937 -0.574 . . . . 2.1000000000000001 111.061 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 73.5 mtt180 -80.17 -25.62 39.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.173 -0.467 . . . . 2.3399999999999999 111.272 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.63 -24.97 26.9 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.256 -0.429 . . . . 1.8500000000000001 111.33 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.7 ttt180 -90.8 -30.43 17.0 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.463 0.477 . . . . 2.0099999999999998 111.387 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -92.29 -43.53 9.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.271 0.357 . . . . 1.53 111.45 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.8 mt-30 . . . . . 0 N--CA 1.465 0.323 0 O-C-N 123.407 0.442 . . . . 1.3100000000000001 111.016 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.521 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.6 mp . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 118.608 -0.711 . . . . 1.8200000000000001 112.728 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.25 -13.09 38.35 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.214 1.942 . . . . 1.0800000000000001 113.886 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.06 -42.5 63.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.26 0.35 . . . . 0.92000000000000004 111.604 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.7 -33.64 64.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.274 -0.421 . . . . 1.8100000000000001 111.388 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 13' ' ' LEU . 11.5 mm -70.91 -38.58 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 123.518 0.511 . . . . 1.4199999999999999 110.108 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.5 m -73.94 -30.22 62.44 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.873 -0.603 . . . . 1.1000000000000001 111.409 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -75.16 -37.34 61.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.22 -0.446 . . . . 1.52 111.259 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.85 -31.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 116.426 -0.352 . . . . 1.7 111.049 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -76.4 -32.63 58.65 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.006 -0.543 . . . . 2.1000000000000001 111.115 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.4 mtt180 -80.97 -26.01 36.9 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.139 -0.482 . . . . 2.3399999999999999 111.221 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -86.5 -23.91 25.75 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.43 0.456 . . . . 1.8500000000000001 111.356 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 25.0 ttt180 -90.4 -33.26 16.1 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.449 0.468 . . . . 2.0099999999999998 111.117 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -89.29 -42.12 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.368 0.417 . . . . 1.53 111.421 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.5 mt-30 . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.929 0.395 . . . . 1.3100000000000001 111.052 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 17' ' ' ILE . 4.1 mp . . . . . 0 CA--C 1.544 0.734 0 CA-C-O 118.619 -0.705 . . . . 1.8200000000000001 112.187 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.425 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 8.3 Cg_exo -73.34 -7.13 19.99 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.312 2.008 . . . . 1.0800000000000001 113.284 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.53 59.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.663 0.385 . . . . 0.92000000000000004 111.675 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.8 -33.09 60.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.182 -0.463 . . . . 1.8100000000000001 111.103 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 13' ' ' LEU . 7.9 mm -71.91 -40.75 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.914 -0.585 . . . . 1.4199999999999999 110.086 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.1 m -74.13 -26.63 60.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.812 -0.631 . . . . 1.1000000000000001 111.075 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.481 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m95 -76.08 -37.71 57.87 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.032 -0.531 . . . . 1.52 111.194 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' ILE . 2.3 pp -77.1 -31.35 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.369 0.418 . . . . 1.7 111.131 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.89 -34.31 59.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.932 -0.576 . . . . 2.1000000000000001 111.032 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.95 -24.61 38.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.561 . . . . 2.3399999999999999 111.295 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 29.0 tttm -86.55 -23.63 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.459 0.474 . . . . 1.8500000000000001 110.913 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -90.7 -33.81 15.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.109 -0.496 . . . . 2.0099999999999998 111.39 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -89.37 -42.56 11.47 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.418 0.448 . . . . 1.53 111.638 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 55.2 mt-30 . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.968 0.413 . . . . 1.3100000000000001 111.075 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 1.8 tp . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 118.735 -0.65 . . . . 1.8200000000000001 111.922 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.446 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.5 Cg_exo -78.87 -10.55 15.43 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.449 2.099 . . . . 1.0800000000000001 113.661 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -42.55 67.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.647 0.379 . . . . 0.92000000000000004 111.998 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.99 -35.55 69.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.326 -0.397 . . . . 1.8100000000000001 111.404 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.2 mm -70.4 -38.69 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 123.599 0.562 . . . . 1.4199999999999999 110.468 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -72.75 -32.36 65.6 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.952 -0.567 . . . . 1.1000000000000001 111.398 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -73.9 -38.05 64.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.186 -0.461 . . . . 1.52 111.519 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.28 -34.04 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.274 0.359 . . . . 1.7 111.481 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.53 -35.43 63.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.195 -0.457 . . . . 2.1000000000000001 111.413 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 94.4 mtt180 -78.54 -28.53 46.08 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.153 -0.476 . . . . 2.3399999999999999 111.489 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -85.47 -20.53 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.361 -0.382 . . . . 1.8500000000000001 111.666 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 31.3 ttt180 -92.43 -31.13 15.4 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.38 0.425 . . . . 2.0099999999999998 110.989 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.38 -41.37 12.16 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.427 0.454 . . . . 1.53 111.398 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 52.7 mt-30 . . . . . 0 N--CA 1.465 0.299 0 O-C-N 123.43 0.456 . . . . 1.3100000000000001 111.075 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.5 tp . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 118.768 -0.634 . . . . 1.8200000000000001 111.782 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.45 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.6 Cg_exo -78.89 -10.77 15.36 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.518 2.146 . . . . 1.0800000000000001 113.64 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.7 66.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.906 0.336 . . . . 0.92000000000000004 111.906 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.52 -35.63 70.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.324 -0.398 . . . . 1.8100000000000001 111.255 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.3 mm -70.92 -39.5 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.836 -0.62 . . . . 1.4199999999999999 110.614 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -72.86 -31.25 64.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.041 -0.527 . . . . 1.1000000000000001 111.51 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.83 -37.58 62.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.127 -0.488 . . . . 1.52 111.398 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.51 -33.55 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 123.294 0.371 . . . . 1.7 111.315 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -74.92 -34.92 62.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.503 0.502 . . . . 2.1000000000000001 111.339 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -78.78 -28.39 44.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.079 -0.51 . . . . 2.3399999999999999 111.439 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -85.99 -19.28 30.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.328 0.392 . . . . 1.8500000000000001 111.665 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 36.1 ttt180 -93.34 -31.68 14.58 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.349 0.406 . . . . 2.0099999999999998 110.915 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -89.39 -40.96 12.39 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.422 0.452 . . . . 1.53 111.388 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 . . . . . 0 N--CA 1.466 0.326 0 O-C-N 123.41 0.444 . . . . 1.3100000000000001 111.061 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.451 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 tp . . . . . 0 CA--C 1.545 0.785 0 CA-C-O 118.733 -0.651 . . . . 1.8200000000000001 111.773 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.0 Cg_exo -78.95 -11.44 15.06 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.437 2.091 . . . . 1.0800000000000001 113.66 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.55 69.52 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.004 0.372 . . . . 0.92000000000000004 112.004 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -72.28 -36.26 68.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.291 -0.413 . . . . 1.8100000000000001 111.298 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 20' ' ' ILE . 9.0 mm -70.47 -38.92 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 123.624 0.578 . . . . 1.4199999999999999 110.541 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.0 m -73.0 -31.89 64.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 111.482 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -74.58 -37.26 62.96 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.134 -0.485 . . . . 1.52 111.492 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.73 -33.6 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 123.3 0.375 . . . . 1.7 111.309 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.84 -34.58 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.51 0.506 . . . . 2.1000000000000001 111.324 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.83 -28.65 44.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 2.3399999999999999 111.379 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -86.01 -18.82 31.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.411 0.444 . . . . 1.8500000000000001 111.741 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.9 ttt180 -93.64 -32.0 14.25 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.35 0.406 . . . . 2.0099999999999998 110.896 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.13 -41.58 12.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.168 -0.469 . . . . 1.53 111.426 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 . . . . . 0 N--CA 1.466 0.337 0 O-C-N 123.418 0.449 . . . . 1.3100000000000001 111.07 179.81 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 CA--C 1.544 0.75 0 CA-C-O 118.69 -0.672 . . . . 1.8200000000000001 112.167 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.35 -3.12 12.79 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.284 1.99 . . . . 1.0800000000000001 113.554 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 19' ' ' TRP . . . -74.29 -39.29 63.04 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.617 0.367 . . . . 0.92000000000000004 111.661 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.87 -34.09 57.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.111 -0.495 . . . . 1.8100000000000001 111.194 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -70.88 -40.58 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 116.068 -0.514 . . . . 1.4199999999999999 110.056 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.6 m -74.35 -26.02 59.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.745 -0.661 . . . . 1.1000000000000001 111.087 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.415 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -76.07 -38.11 57.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.972 -0.558 . . . . 1.52 111.086 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -77.02 -31.07 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.274 -0.421 . . . . 1.7 111.022 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -75.85 -34.04 60.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.981 -0.554 . . . . 2.1000000000000001 111.022 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 80.3 mtt180 -80.48 -26.79 38.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.062 -0.517 . . . . 2.3399999999999999 111.272 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 31.7 tttm -85.98 -20.49 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.485 0.491 . . . . 1.8500000000000001 111.041 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.9 ttt180 -94.33 -31.02 14.22 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.36 0.412 . . . . 2.0099999999999998 111.034 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -90.64 -43.56 10.08 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.327 0.392 . . . . 1.53 111.543 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.7 mt-30 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.3100000000000001 111.146 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.1 mp . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 118.628 -0.701 . . . . 1.8200000000000001 112.489 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.94 -7.71 19.42 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.396 2.064 . . . . 1.0800000000000001 114.162 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.67 -42.19 61.67 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.483 0.313 . . . . 0.92000000000000004 111.521 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.33 -34.21 63.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.083 -0.508 . . . . 1.8100000000000001 111.048 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 13' ' ' LEU . 6.4 mm -69.99 -38.24 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.868 -0.606 . . . . 1.4199999999999999 109.984 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.8 m -74.47 -27.79 60.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.757 -0.656 . . . . 1.1000000000000001 111.242 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -75.22 -38.48 60.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 1.52 111.202 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.2 pp -76.45 -31.16 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.192 -0.458 . . . . 1.7 111.103 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -75.85 -33.18 60.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.939 -0.573 . . . . 2.1000000000000001 111.113 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.69 -26.28 37.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.038 -0.528 . . . . 2.3399999999999999 111.077 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -85.78 -21.63 28.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.065 -0.516 . . . . 1.8500000000000001 111.413 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 24.9 ttt180 -93.75 -32.77 13.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.145 -0.48 . . . . 2.0099999999999998 111.209 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.28 -43.55 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.349 0.405 . . . . 1.53 111.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.6 mt-30 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.007 0.432 . . . . 1.3100000000000001 111.131 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.447 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 tp . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 118.811 -0.614 . . . . 1.8200000000000001 111.845 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.3 Cg_exo -78.99 -10.41 15.3 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.437 2.091 . . . . 1.0800000000000001 113.743 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -41.85 67.28 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.022 0.378 . . . . 0.92000000000000004 112.022 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.01 -35.69 69.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.331 -0.395 . . . . 1.8100000000000001 111.355 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.4 mm -70.56 -39.53 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 123.658 0.599 . . . . 1.4199999999999999 110.463 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -72.56 -31.5 65.3 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.025 -0.534 . . . . 1.1000000000000001 111.549 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.72 -37.37 62.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.203 -0.453 . . . . 1.52 111.415 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.4 pp -75.9 -33.68 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.273 0.358 . . . . 1.7 111.323 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.61 -35.01 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.486 0.491 . . . . 2.1000000000000001 111.232 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -78.8 -27.97 44.49 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.532 0.52 . . . . 2.3399999999999999 111.506 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -86.41 -19.87 29.04 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.39 0.431 . . . . 1.8500000000000001 111.593 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.5 ttt180 -92.98 -31.64 14.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.332 0.395 . . . . 2.0099999999999998 110.909 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -89.78 -41.36 11.91 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.418 0.448 . . . . 1.53 111.361 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 . . . . . 0 N--CA 1.465 0.312 0 O-C-N 123.376 0.423 . . . . 1.3100000000000001 110.992 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.613 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.463 -0.255 . . . . 2.71 112.463 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.4 tp -62.92 -37.22 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 122.958 0.503 . . . . 2.4500000000000002 111.743 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.73 -28.94 66.18 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.148 -0.478 . . . . 1.6699999999999999 112.896 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.17 -43.29 43.38 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.581 0.352 . . . . 1.6200000000000001 111.179 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.2 m -73.74 -22.7 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.403 -0.362 . . . . 1.46 111.666 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.561 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 9.2 tp -84.42 -39.95 18.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.121 -0.49 . . . . 1.49 111.325 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -84.69 -11.42 55.9 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.844 0.683 . . . . 2.1899999999999999 112.844 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.42 -36.05 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 122.903 0.127 . . . . 1.3 111.331 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 5.2 mt -107.15 -34.4 7.15 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.59 0.589 . . . . 1.48 112.59 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.561 ' OG1' ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -93.0 36.22 1.04 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.968 0.413 . . . . 1.46 111.382 -179.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -140.05 -46.11 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.976 -0.556 . . . . 1.51 111.487 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.66 94.51 0.82 Allowed Glycine 0 C--N 1.338 0.689 0 O-C-N 123.541 0.525 . . . . 1.3899999999999999 112.541 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.3 mp -105.99 -46.86 0.13 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 118.673 -0.679 . . . . 1.8200000000000001 112.306 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.28 -12.07 31.25 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.275 1.983 . . . . 1.0800000000000001 113.779 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' HD1' ' A' ' 19' ' ' TRP . . . -72.72 -40.73 65.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.457 0.303 . . . . 0.92000000000000004 111.472 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.43 -34.82 68.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.173 -0.467 . . . . 1.8100000000000001 110.908 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -69.91 -35.77 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.793 -0.64 . . . . 1.4199999999999999 109.99 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.4 m -74.62 -30.39 61.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.659 -0.7 . . . . 1.1000000000000001 111.251 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.409 ' HD1' ' O ' ' A' ' 15' ' ' ALA . 15.1 m95 -74.6 -37.81 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.286 -0.416 . . . . 1.52 111.23 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 pp -76.03 -30.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 116.341 -0.39 . . . . 1.7 111.134 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -76.36 -32.57 58.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.011 -0.54 . . . . 2.1000000000000001 111.058 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.9 mtt180 -80.97 -26.38 36.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.174 -0.467 . . . . 2.3399999999999999 111.096 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.26 -23.87 28.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.094 -0.503 . . . . 1.8500000000000001 111.232 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.1 ttt180 -91.06 -31.26 16.34 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.534 0.521 . . . . 2.0099999999999998 111.304 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.39 -44.44 9.65 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.257 0.348 . . . . 1.53 111.358 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 53.5 mt-30 -100.03 -50.49 3.97 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.396 0.435 . . . . 1.3100000000000001 111.075 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.134 0 CA-C-N 116.067 -0.515 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.437 -0.265 . . . . 2.71 112.437 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 1.2 mp -65.35 -40.41 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.836 0.454 . . . . 2.4500000000000002 111.1 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.0 -33.81 70.29 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.486 0.491 . . . . 1.6699999999999999 113.236 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.514 ' O ' HG21 ' A' ' 8' ' ' VAL . . . -72.87 -48.76 34.71 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.588 0.355 . . . . 1.6200000000000001 111.37 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 1' ' ' GLY . 25.2 t -66.73 -28.46 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.485 -0.325 . . . . 1.46 110.517 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 7.9 tp -76.06 -39.43 55.48 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.364 -0.38 . . . . 1.49 111.2 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -74.91 -22.86 58.36 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.217 0.451 . . . . 2.1899999999999999 112.217 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 4' ' ' ALA . 48.4 t -91.4 -21.84 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 110.079 -0.341 . . . . 1.3 110.079 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.6 mp -93.67 -11.31 31.89 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.133 0.42 . . . . 1.48 112.133 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 p -90.21 -29.58 18.12 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.146 0.424 . . . . 1.46 112.146 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -90.9 -46.73 8.01 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.222 0.326 . . . . 1.51 111.732 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.15 97.35 1.74 Allowed Glycine 0 C--N 1.339 0.696 0 O-C-N 123.421 0.451 . . . . 1.3899999999999999 112.557 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.34 -48.58 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 118.7 -0.667 . . . . 1.8200000000000001 111.647 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.98 -5.62 14.64 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.395 2.064 . . . . 1.0800000000000001 113.325 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.61 67.94 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 122.712 0.405 . . . . 0.92000000000000004 111.911 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tp -72.76 -35.42 67.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 1.8100000000000001 110.951 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mm -71.01 -36.7 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.856 -0.611 . . . . 1.4199999999999999 110.14 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -74.6 -29.81 61.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.85 -0.614 . . . . 1.1000000000000001 111.388 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -75.75 -36.91 59.74 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.421 0.45 . . . . 1.52 111.204 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -76.31 -31.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.301 -0.409 . . . . 1.7 110.947 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -75.96 -34.16 59.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.937 -0.574 . . . . 2.1000000000000001 111.061 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 73.5 mtt180 -80.17 -25.62 39.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.173 -0.467 . . . . 2.3399999999999999 111.272 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.63 -24.97 26.9 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.256 -0.429 . . . . 1.8500000000000001 111.33 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.7 ttt180 -90.8 -30.43 17.0 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.463 0.477 . . . . 2.0099999999999998 111.387 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -92.29 -43.53 9.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.271 0.357 . . . . 1.53 111.45 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.8 mt-30 -102.61 -50.45 3.56 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.407 0.442 . . . . 1.3100000000000001 111.016 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.096 -0.502 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 112.647 -0.181 . . . . 2.71 112.647 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 mt -66.74 -44.03 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.944 0.498 . . . . 2.4500000000000002 110.875 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.17 -26.5 74.17 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.01 -0.541 . . . . 1.6699999999999999 113.005 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.12 -44.92 28.68 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.604 0.362 . . . . 1.6200000000000001 111.112 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 1' ' ' GLY . 13.1 m -73.17 -21.72 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 123.263 0.352 . . . . 1.46 111.491 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tt -85.74 -32.6 21.78 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.165 -0.47 . . . . 1.49 110.772 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -84.87 -15.17 45.55 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.129 -0.487 . . . . 2.1899999999999999 112.273 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.16 -36.79 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 O-C-N 122.975 0.172 . . . . 1.3 111.06 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 6.3 mp -96.41 -40.35 9.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.78 0.289 . . . . 1.48 111.78 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -95.59 73.07 3.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.41 0.624 . . . . 1.46 110.685 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -149.76 -46.17 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.239 -0.891 . . . . 1.51 110.898 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.8 101.77 0.37 Allowed Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.989 -0.55 . . . . 1.3899999999999999 112.236 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.521 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.6 mp -94.95 -38.59 0.29 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.608 -0.711 . . . . 1.8200000000000001 112.728 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.25 -13.09 38.35 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.214 1.942 . . . . 1.0800000000000001 113.886 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.06 -42.5 63.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.26 0.35 . . . . 0.92000000000000004 111.604 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.7 -33.64 64.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.274 -0.421 . . . . 1.8100000000000001 111.388 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 13' ' ' LEU . 11.5 mm -70.91 -38.58 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 123.518 0.511 . . . . 1.4199999999999999 110.108 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.5 m -73.94 -30.22 62.44 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.873 -0.603 . . . . 1.1000000000000001 111.409 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -75.16 -37.34 61.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.22 -0.446 . . . . 1.52 111.259 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.85 -31.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 116.426 -0.352 . . . . 1.7 111.049 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -76.4 -32.63 58.65 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.006 -0.543 . . . . 2.1000000000000001 111.115 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.4 mtt180 -80.97 -26.01 36.9 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.139 -0.482 . . . . 2.3399999999999999 111.221 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -86.5 -23.91 25.75 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.43 0.456 . . . . 1.8500000000000001 111.356 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 25.0 ttt180 -90.4 -33.26 16.1 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.449 0.468 . . . . 2.0099999999999998 111.117 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -89.29 -42.12 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.368 0.417 . . . . 1.53 111.421 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.5 mt-30 -105.19 -50.6 3.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.929 0.395 . . . . 1.3100000000000001 111.052 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.626 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.5 -0.24 . . . . 2.71 112.5 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.2 tp -60.81 -36.29 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.092 0.557 . . . . 2.4500000000000002 111.861 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -71.22 -32.74 65.22 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.984 -0.553 . . . . 1.6699999999999999 113.437 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.57 -45.81 28.87 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.493 0.317 . . . . 1.6200000000000001 111.38 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.7 m -65.17 -37.09 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 116.317 -0.401 . . . . 1.46 111.355 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.81 -38.17 64.68 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.763 -0.653 . . . . 1.49 111.157 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 27.1 tttp -74.54 -11.66 60.27 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.284 0.365 . . . . 2.1899999999999999 111.747 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -110.46 -7.19 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.202 0.314 . . . . 1.3 111.552 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -107.6 -41.39 5.05 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.579 0.585 . . . . 1.48 112.579 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 43.3 p -84.78 1.07 48.4 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.573 0.583 . . . . 1.46 112.573 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.9 p -95.47 -44.52 7.49 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.667 -0.242 . . . . 1.51 111.57 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.63 115.6 3.55 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 123.457 0.473 . . . . 1.3899999999999999 112.604 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 17' ' ' ILE . 4.1 mp -128.98 -45.81 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.619 -0.705 . . . . 1.8200000000000001 112.187 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.425 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 8.3 Cg_exo -73.34 -7.13 19.99 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.312 2.008 . . . . 1.0800000000000001 113.284 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.53 59.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.663 0.385 . . . . 0.92000000000000004 111.675 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.8 -33.09 60.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.182 -0.463 . . . . 1.8100000000000001 111.103 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 13' ' ' LEU . 7.9 mm -71.91 -40.75 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.914 -0.585 . . . . 1.4199999999999999 110.086 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.1 m -74.13 -26.63 60.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.812 -0.631 . . . . 1.1000000000000001 111.075 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.481 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m95 -76.08 -37.71 57.87 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.032 -0.531 . . . . 1.52 111.194 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' ILE . 2.3 pp -77.1 -31.35 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.369 0.418 . . . . 1.7 111.131 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.89 -34.31 59.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.932 -0.576 . . . . 2.1000000000000001 111.032 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.95 -24.61 38.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.561 . . . . 2.3399999999999999 111.295 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 29.0 tttm -86.55 -23.63 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.459 0.474 . . . . 1.8500000000000001 110.913 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -90.7 -33.81 15.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.109 -0.496 . . . . 2.0099999999999998 111.39 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -89.37 -42.56 11.47 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.418 0.448 . . . . 1.53 111.638 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 55.2 mt-30 -104.64 -50.16 3.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.968 0.413 . . . . 1.3100000000000001 111.075 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.598 -0.201 . . . . 2.71 112.598 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.455 HD13 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp -62.27 -39.53 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.992 0.517 . . . . 2.4500000000000002 112.327 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.606 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -70.41 -31.38 68.5 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.015 -0.538 . . . . 1.6699999999999999 113.076 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -74.97 -45.73 40.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 122.648 0.379 . . . . 1.6200000000000001 111.354 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.3 m -65.85 -38.62 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 123.392 0.433 . . . . 1.46 111.484 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.22 -30.17 63.31 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.984 -0.553 . . . . 1.49 111.179 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -71.93 -36.28 69.9 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.487 0.492 . . . . 2.1899999999999999 111.5 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 4' ' ' ALA . 7.9 m -87.45 -15.61 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 123.376 0.423 . . . . 1.3 112.089 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -92.94 -23.2 18.81 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.325 0.391 . . . . 1.48 112.019 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.0 p -87.44 -1.05 57.66 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.36 0.504 . . . . 1.46 112.36 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -110.6 -46.16 3.42 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.914 0.338 . . . . 1.51 111.914 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.64 110.62 4.07 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 121.408 -0.425 . . . . 1.3899999999999999 112.886 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 1.8 tp -138.72 -46.78 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.735 -0.65 . . . . 1.8200000000000001 111.922 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.446 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.5 Cg_exo -78.87 -10.55 15.43 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.449 2.099 . . . . 1.0800000000000001 113.661 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -42.55 67.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.647 0.379 . . . . 0.92000000000000004 111.998 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.99 -35.55 69.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.326 -0.397 . . . . 1.8100000000000001 111.404 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.2 mm -70.4 -38.69 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 123.599 0.562 . . . . 1.4199999999999999 110.468 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -72.75 -32.36 65.6 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.952 -0.567 . . . . 1.1000000000000001 111.398 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -73.9 -38.05 64.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.186 -0.461 . . . . 1.52 111.519 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.28 -34.04 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.274 0.359 . . . . 1.7 111.481 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.53 -35.43 63.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.195 -0.457 . . . . 2.1000000000000001 111.413 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 94.4 mtt180 -78.54 -28.53 46.08 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.153 -0.476 . . . . 2.3399999999999999 111.489 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -85.47 -20.53 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.361 -0.382 . . . . 1.8500000000000001 111.666 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 31.3 ttt180 -92.43 -31.13 15.4 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.38 0.425 . . . . 2.0099999999999998 110.989 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.38 -41.37 12.16 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.427 0.454 . . . . 1.53 111.398 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 52.7 mt-30 -106.37 -49.6 3.31 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.43 0.456 . . . . 1.3100000000000001 111.075 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.092 -0.504 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.471 -0.252 . . . . 2.71 112.471 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.431 HD13 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp -63.11 -40.08 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 122.796 0.438 . . . . 2.4500000000000002 112.069 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.431 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -70.49 -32.43 67.9 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.961 -0.563 . . . . 1.6699999999999999 113.032 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.631 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -72.55 -47.32 49.19 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.528 0.331 . . . . 1.6200000000000001 111.23 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 1' ' ' GLY . 5.9 m -66.2 -36.02 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 123.365 0.416 . . . . 1.46 111.598 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.71 -32.49 65.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.126 -0.488 . . . . 1.49 111.456 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.6 -33.23 64.5 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.439 0.462 . . . . 2.1899999999999999 111.853 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 4' ' ' ALA . 8.4 m -90.48 -9.75 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.004 0.372 . . . . 1.3 112.004 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 5.3 tp -99.26 -26.8 14.05 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.22 0.325 . . . . 1.48 111.701 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p -84.45 -7.01 59.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.383 0.512 . . . . 1.46 112.383 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -102.94 -45.86 4.84 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.149 0.28 . . . . 1.51 111.729 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.35 108.14 3.56 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 121.38 -0.438 . . . . 1.3899999999999999 112.862 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.5 tp -136.38 -46.63 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 CA-C-O 118.768 -0.634 . . . . 1.8200000000000001 111.782 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.45 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.6 Cg_exo -78.89 -10.77 15.36 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.518 2.146 . . . . 1.0800000000000001 113.64 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.7 66.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.906 0.336 . . . . 0.92000000000000004 111.906 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.52 -35.63 70.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.324 -0.398 . . . . 1.8100000000000001 111.255 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.3 mm -70.92 -39.5 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.836 -0.62 . . . . 1.4199999999999999 110.614 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -72.86 -31.25 64.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.041 -0.527 . . . . 1.1000000000000001 111.51 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.83 -37.58 62.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.127 -0.488 . . . . 1.52 111.398 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.51 -33.55 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 123.294 0.371 . . . . 1.7 111.315 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -74.92 -34.92 62.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.503 0.502 . . . . 2.1000000000000001 111.339 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -78.78 -28.39 44.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.079 -0.51 . . . . 2.3399999999999999 111.439 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -85.99 -19.28 30.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.328 0.392 . . . . 1.8500000000000001 111.665 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 36.1 ttt180 -93.34 -31.68 14.58 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.349 0.406 . . . . 2.0099999999999998 110.915 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -89.39 -40.96 12.39 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.422 0.452 . . . . 1.53 111.388 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -109.47 -50.63 2.97 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.41 0.444 . . . . 1.3100000000000001 111.061 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.084 -0.507 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.602 -0.199 . . . . 2.71 112.602 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp -60.59 -37.92 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 112.378 0.51 . . . . 2.4500000000000002 112.378 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.464 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -70.26 -35.26 69.77 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.021 -0.536 . . . . 1.6699999999999999 113.027 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.632 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -71.86 -46.42 58.0 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 122.564 0.346 . . . . 1.6200000000000001 111.379 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 1' ' ' GLY . 3.9 m -66.12 -36.7 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 123.379 0.425 . . . . 1.46 111.627 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.3 -32.44 66.58 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.474 0.484 . . . . 1.49 111.407 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -73.9 -33.24 63.93 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.398 0.436 . . . . 2.1899999999999999 111.999 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 4' ' ' ALA . 9.2 m -89.71 -11.09 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.024 0.379 . . . . 1.3 112.024 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.7 tp -97.82 -27.8 14.15 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.266 0.353 . . . . 1.48 111.715 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 p -84.16 -10.84 57.43 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.575 0.584 . . . . 1.46 112.575 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 p -99.14 -45.46 5.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.246 0.341 . . . . 1.51 111.748 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.23 107.5 3.41 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 123.453 0.471 . . . . 1.3899999999999999 112.788 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.451 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 tp -136.04 -46.54 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.733 -0.651 . . . . 1.8200000000000001 111.773 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.0 Cg_exo -78.95 -11.44 15.06 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.437 2.091 . . . . 1.0800000000000001 113.66 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.55 69.52 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.004 0.372 . . . . 0.92000000000000004 112.004 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -72.28 -36.26 68.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.291 -0.413 . . . . 1.8100000000000001 111.298 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 20' ' ' ILE . 9.0 mm -70.47 -38.92 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 123.624 0.578 . . . . 1.4199999999999999 110.541 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.0 m -73.0 -31.89 64.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 111.482 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -74.58 -37.26 62.96 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.134 -0.485 . . . . 1.52 111.492 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.73 -33.6 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 123.3 0.375 . . . . 1.7 111.309 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.84 -34.58 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.51 0.506 . . . . 2.1000000000000001 111.324 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.83 -28.65 44.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 2.3399999999999999 111.379 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -86.01 -18.82 31.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.411 0.444 . . . . 1.8500000000000001 111.741 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.9 ttt180 -93.64 -32.0 14.25 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.35 0.406 . . . . 2.0099999999999998 110.896 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.13 -41.58 12.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.168 -0.469 . . . . 1.53 111.426 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -109.16 -50.37 3.01 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.418 0.449 . . . . 1.3100000000000001 111.07 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.081 -0.509 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.624 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.541 -0.224 . . . . 2.71 112.541 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.406 HD13 ' N ' ' A' ' 3' ' ' GLY . 2.2 pp -62.11 -37.08 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 122.935 0.494 . . . . 2.4500000000000002 112.283 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.613 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -71.18 -31.9 66.01 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.952 -0.567 . . . . 1.6699999999999999 113.108 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.02 -45.1 36.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 122.58 0.352 . . . . 1.6200000000000001 111.597 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 1' ' ' GLY . 5.2 m -69.71 -34.19 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 123.31 0.382 . . . . 1.46 111.882 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tt -75.7 -41.52 53.4 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.132 -0.485 . . . . 1.49 111.065 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.613 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.8 tttp -73.76 -17.94 61.04 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.19 0.441 . . . . 2.1899999999999999 112.19 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 p -97.57 -23.37 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 O-C-N 123.246 0.341 . . . . 1.3 111.519 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -89.59 -39.11 13.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.322 0.49 . . . . 1.48 112.322 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.5 p -87.76 53.32 2.73 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.425 0.631 . . . . 1.46 111.318 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 p -141.53 -45.16 0.36 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.413 -0.812 . . . . 1.51 111.014 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.75 87.5 0.32 Allowed Glycine 0 C--N 1.34 0.771 0 O-C-N 123.52 0.512 . . . . 1.3899999999999999 112.209 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.15 -44.74 0.35 Allowed Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 118.69 -0.672 . . . . 1.8200000000000001 112.167 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.35 -3.12 12.79 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.284 1.99 . . . . 1.0800000000000001 113.554 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 19' ' ' TRP . . . -74.29 -39.29 63.04 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.617 0.367 . . . . 0.92000000000000004 111.661 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.87 -34.09 57.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.111 -0.495 . . . . 1.8100000000000001 111.194 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -70.88 -40.58 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 116.068 -0.514 . . . . 1.4199999999999999 110.056 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.6 m -74.35 -26.02 59.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.745 -0.661 . . . . 1.1000000000000001 111.087 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.415 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -76.07 -38.11 57.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.972 -0.558 . . . . 1.52 111.086 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -77.02 -31.07 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.274 -0.421 . . . . 1.7 111.022 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -75.85 -34.04 60.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.981 -0.554 . . . . 2.1000000000000001 111.022 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 80.3 mtt180 -80.48 -26.79 38.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.062 -0.517 . . . . 2.3399999999999999 111.272 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 31.7 tttm -85.98 -20.49 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.485 0.491 . . . . 1.8500000000000001 111.041 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.9 ttt180 -94.33 -31.02 14.22 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.36 0.412 . . . . 2.0099999999999998 111.034 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -90.64 -43.56 10.08 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.327 0.392 . . . . 1.53 111.543 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.7 mt-30 -99.44 -50.59 4.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.3100000000000001 111.146 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 116.094 -0.503 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 112.765 -0.134 . . . . 2.71 112.765 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pt -62.92 -42.11 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.027 0.531 . . . . 2.4500000000000002 112.154 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -70.61 -28.06 71.57 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.84 -0.618 . . . . 1.6699999999999999 113.23 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.7 31.86 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.581 0.352 . . . . 1.6200000000000001 111.383 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 1' ' ' GLY . 8.6 m -73.18 -24.35 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 116.491 -0.322 . . . . 1.46 111.642 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 4.0 tp -84.34 -39.1 19.53 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.222 -0.445 . . . . 1.49 111.282 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 2.5 tptp -81.21 -18.51 45.89 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.817 0.673 . . . . 2.1899999999999999 112.817 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.7 t -106.46 -42.75 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 122.961 0.163 . . . . 1.3 111.387 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.44 -35.29 13.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.261 0.467 . . . . 1.48 112.261 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -95.71 64.18 2.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.456 0.646 . . . . 1.46 110.656 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.9 p -145.55 -45.05 0.21 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.176 -0.92 . . . . 1.51 110.991 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.39 112.5 1.36 Allowed Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.019 -0.537 . . . . 1.3899999999999999 112.305 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.1 mp -103.67 -44.7 0.18 Allowed Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.628 -0.701 . . . . 1.8200000000000001 112.489 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.94 -7.71 19.42 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.396 2.064 . . . . 1.0800000000000001 114.162 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.67 -42.19 61.67 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.483 0.313 . . . . 0.92000000000000004 111.521 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.33 -34.21 63.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.083 -0.508 . . . . 1.8100000000000001 111.048 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 13' ' ' LEU . 6.4 mm -69.99 -38.24 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.868 -0.606 . . . . 1.4199999999999999 109.984 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.8 m -74.47 -27.79 60.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.757 -0.656 . . . . 1.1000000000000001 111.242 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -75.22 -38.48 60.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 1.52 111.202 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.2 pp -76.45 -31.16 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.192 -0.458 . . . . 1.7 111.103 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -75.85 -33.18 60.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.939 -0.573 . . . . 2.1000000000000001 111.113 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.69 -26.28 37.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.038 -0.528 . . . . 2.3399999999999999 111.077 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -85.78 -21.63 28.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.065 -0.516 . . . . 1.8500000000000001 111.413 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 24.9 ttt180 -93.75 -32.77 13.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.145 -0.48 . . . . 2.0099999999999998 111.209 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.28 -43.55 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.349 0.405 . . . . 1.53 111.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.6 mt-30 -102.26 -50.52 3.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.007 0.432 . . . . 1.3100000000000001 111.131 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 116.102 -0.499 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.618 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.478 -0.249 . . . . 2.71 112.478 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp -63.45 -37.69 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.407 0.521 . . . . 2.4500000000000002 112.407 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.432 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -70.82 -32.23 66.83 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 116.012 -0.54 . . . . 1.6699999999999999 112.873 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -74.77 -47.66 29.73 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.575 0.35 . . . . 1.6200000000000001 111.367 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.6 m -65.12 -36.58 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.324 0.39 . . . . 1.46 111.447 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.13 -29.55 61.87 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.157 -0.474 . . . . 1.49 111.142 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -72.66 -34.24 67.11 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.442 0.464 . . . . 2.1899999999999999 111.569 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 4' ' ' ALA . 5.6 m -91.25 -9.97 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.115 0.413 . . . . 1.3 112.115 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.2 tp -97.78 -27.28 14.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.225 0.328 . . . . 1.48 111.686 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.3 p -85.17 -6.45 59.28 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.432 0.53 . . . . 1.46 112.432 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.6 p -103.49 -45.88 4.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.798 0.296 . . . . 1.51 111.798 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.19 109.81 3.85 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 121.374 -0.441 . . . . 1.3899999999999999 112.913 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.447 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 tp -136.55 -46.56 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.811 -0.614 . . . . 1.8200000000000001 111.845 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.3 Cg_exo -78.99 -10.41 15.3 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.437 2.091 . . . . 1.0800000000000001 113.743 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -41.85 67.28 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.022 0.378 . . . . 0.92000000000000004 112.022 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.01 -35.69 69.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.331 -0.395 . . . . 1.8100000000000001 111.355 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.4 mm -70.56 -39.53 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 123.658 0.599 . . . . 1.4199999999999999 110.463 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -72.56 -31.5 65.3 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.025 -0.534 . . . . 1.1000000000000001 111.549 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.72 -37.37 62.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.203 -0.453 . . . . 1.52 111.415 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.4 pp -75.9 -33.68 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.273 0.358 . . . . 1.7 111.323 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.61 -35.01 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.486 0.491 . . . . 2.1000000000000001 111.232 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -78.8 -27.97 44.49 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.532 0.52 . . . . 2.3399999999999999 111.506 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -86.41 -19.87 29.04 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.39 0.431 . . . . 1.8500000000000001 111.593 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.5 ttt180 -92.98 -31.64 14.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.332 0.395 . . . . 2.0099999999999998 110.909 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -89.78 -41.36 11.91 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.418 0.448 . . . . 1.53 111.361 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -108.81 -50.71 2.98 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.376 0.423 . . . . 1.3100000000000001 110.992 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.126 -0.488 . . . . 0.96999999999999997 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.3 mp . . . . . 0 CA--C 1.545 0.784 0 CA-C-O 118.673 -0.679 . . . . 1.5 112.306 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.28 -12.07 31.25 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.275 1.983 . . . . 0.92 113.779 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' O ' ' HD1' ' A' ' 19' ' ' TRP . . . -72.72 -40.73 65.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.457 0.303 . . . . 0.88 111.472 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.43 -34.82 68.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.173 -0.467 . . . . 1.23 110.908 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -69.91 -35.77 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.793 -0.64 . . . . 0.64 109.99 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.4 m -74.62 -30.39 61.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.659 -0.7 . . . . 0.88 111.251 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.401 ' HD1' ' O ' ' A' ' 15' ' ' ALA . 15.1 m95 -74.6 -37.81 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.286 -0.416 . . . . 1.24 111.23 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 pp -76.03 -30.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 116.341 -0.39 . . . . 1.33 111.134 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -76.36 -32.57 58.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.011 -0.54 . . . . 1.58 111.058 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.9 mtt180 -80.97 -26.38 36.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.174 -0.467 . . . . 2.06 111.096 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.26 -23.87 28.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.094 -0.503 . . . . 1.28 111.232 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.1 ttt180 -91.06 -31.26 16.34 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.534 0.521 . . . . 1.78 111.304 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.39 -44.44 9.65 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.257 0.348 . . . . 1.5 111.358 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 53.5 mt-30 . . . . . 0 N--CA 1.466 0.359 0 O-C-N 123.396 0.435 . . . . 1.31 111.075 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 118.7 -0.667 . . . . 1.5 111.647 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.98 -5.62 14.64 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.395 2.064 . . . . 0.92 113.325 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.61 67.94 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 122.712 0.405 . . . . 0.88 111.911 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tp -72.76 -35.42 67.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 1.23 110.951 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mm -71.01 -36.7 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.856 -0.611 . . . . 0.64 110.14 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -74.6 -29.81 61.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.85 -0.614 . . . . 0.88 111.388 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -75.75 -36.91 59.74 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.421 0.45 . . . . 1.24 111.204 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -76.31 -31.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.301 -0.409 . . . . 1.33 110.947 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -75.96 -34.16 59.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.937 -0.574 . . . . 1.58 111.061 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 73.5 mtt180 -80.17 -25.62 39.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.173 -0.467 . . . . 2.06 111.272 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.63 -24.97 26.9 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.256 -0.429 . . . . 1.28 111.33 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.7 ttt180 -90.8 -30.43 17.0 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.463 0.477 . . . . 1.78 111.387 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -92.29 -43.53 9.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.271 0.357 . . . . 1.5 111.45 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.8 mt-30 . . . . . 0 N--CA 1.465 0.323 0 O-C-N 123.407 0.442 . . . . 1.31 111.016 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.6 mp . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 118.608 -0.711 . . . . 1.5 112.728 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.25 -13.09 38.35 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.214 1.942 . . . . 0.92 113.886 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.06 -42.5 63.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.26 0.35 . . . . 0.88 111.604 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.7 -33.64 64.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.274 -0.421 . . . . 1.23 111.388 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 13' ' ' LEU . 11.5 mm -70.91 -38.58 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 123.518 0.511 . . . . 0.64 110.108 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.5 m -73.94 -30.22 62.44 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.873 -0.603 . . . . 0.88 111.409 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -75.16 -37.34 61.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.22 -0.446 . . . . 1.24 111.259 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.85 -31.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 116.426 -0.352 . . . . 1.33 111.049 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -76.4 -32.63 58.65 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.006 -0.543 . . . . 1.58 111.115 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.4 mtt180 -80.97 -26.01 36.9 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.139 -0.482 . . . . 2.06 111.221 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -86.5 -23.91 25.75 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.43 0.456 . . . . 1.28 111.356 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 25.0 ttt180 -90.4 -33.26 16.1 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.449 0.468 . . . . 1.78 111.117 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -89.29 -42.12 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.368 0.417 . . . . 1.5 111.421 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.5 mt-30 . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.929 0.395 . . . . 1.31 111.052 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' HG12 ' A' ' 17' ' ' ILE . 4.1 mp . . . . . 0 CA--C 1.544 0.734 0 CA-C-O 118.619 -0.705 . . . . 1.5 112.187 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.34 -7.13 19.99 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.312 2.008 . . . . 0.92 113.284 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.53 59.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.663 0.385 . . . . 0.88 111.675 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.8 -33.09 60.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.182 -0.463 . . . . 1.23 111.103 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 13' ' ' LEU . 7.9 mm -71.91 -40.75 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.914 -0.585 . . . . 0.64 110.086 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.1 m -74.13 -26.63 60.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.812 -0.631 . . . . 0.88 111.075 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m95 -76.08 -37.71 57.87 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.032 -0.531 . . . . 1.24 111.194 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' ILE . 2.3 pp -77.1 -31.35 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.369 0.418 . . . . 1.33 111.131 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.89 -34.31 59.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.932 -0.576 . . . . 1.58 111.032 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.95 -24.61 38.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.561 . . . . 2.06 111.295 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 29.0 tttm -86.55 -23.63 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.459 0.474 . . . . 1.28 110.913 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -90.7 -33.81 15.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.109 -0.496 . . . . 1.78 111.39 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -89.37 -42.56 11.47 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.418 0.448 . . . . 1.5 111.638 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 55.2 mt-30 . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.968 0.413 . . . . 1.31 111.075 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.8 tp . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 118.735 -0.65 . . . . 1.5 111.922 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.87 -10.55 15.43 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.449 2.099 . . . . 0.92 113.661 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -42.55 67.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.647 0.379 . . . . 0.88 111.998 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.99 -35.55 69.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.404 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.2 mm -70.4 -38.69 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 123.599 0.562 . . . . 0.64 110.468 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -72.75 -32.36 65.6 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.952 -0.567 . . . . 0.88 111.398 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -73.9 -38.05 64.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.186 -0.461 . . . . 1.24 111.519 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.28 -34.04 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.274 0.359 . . . . 1.33 111.481 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.53 -35.43 63.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.195 -0.457 . . . . 1.58 111.413 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 94.4 mtt180 -78.54 -28.53 46.08 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.153 -0.476 . . . . 2.06 111.489 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -85.47 -20.53 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.361 -0.382 . . . . 1.28 111.666 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 31.3 ttt180 -92.43 -31.13 15.4 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.38 0.425 . . . . 1.78 110.989 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.38 -41.37 12.16 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.427 0.454 . . . . 1.5 111.398 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 52.7 mt-30 . . . . . 0 N--CA 1.465 0.299 0 O-C-N 123.43 0.456 . . . . 1.31 111.075 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.5 tp . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 118.768 -0.634 . . . . 1.5 111.782 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.89 -10.77 15.36 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.518 2.146 . . . . 0.92 113.64 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.7 66.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.906 0.336 . . . . 0.88 111.906 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.52 -35.63 70.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.324 -0.398 . . . . 1.23 111.255 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.3 mm -70.92 -39.5 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.836 -0.62 . . . . 0.64 110.614 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -72.86 -31.25 64.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.041 -0.527 . . . . 0.88 111.51 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.83 -37.58 62.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.127 -0.488 . . . . 1.24 111.398 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.51 -33.55 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 123.294 0.371 . . . . 1.33 111.315 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -74.92 -34.92 62.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.503 0.502 . . . . 1.58 111.339 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -78.78 -28.39 44.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.079 -0.51 . . . . 2.06 111.439 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -85.99 -19.28 30.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.328 0.392 . . . . 1.28 111.665 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 36.1 ttt180 -93.34 -31.68 14.58 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.349 0.406 . . . . 1.78 110.915 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -89.39 -40.96 12.39 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.422 0.452 . . . . 1.5 111.388 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 . . . . . 0 N--CA 1.466 0.326 0 O-C-N 123.41 0.444 . . . . 1.31 111.061 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.1 tp . . . . . 0 CA--C 1.545 0.785 0 CA-C-O 118.733 -0.651 . . . . 1.5 111.773 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.95 -11.44 15.06 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.437 2.091 . . . . 0.92 113.66 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.55 69.52 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.004 0.372 . . . . 0.88 112.004 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -72.28 -36.26 68.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.291 -0.413 . . . . 1.23 111.298 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -70.47 -38.92 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 123.624 0.578 . . . . 0.64 110.541 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.0 m -73.0 -31.89 64.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.88 111.482 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -74.58 -37.26 62.96 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.134 -0.485 . . . . 1.24 111.492 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.73 -33.6 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 123.3 0.375 . . . . 1.33 111.309 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.84 -34.58 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.51 0.506 . . . . 1.58 111.324 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.83 -28.65 44.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 2.06 111.379 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -86.01 -18.82 31.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.411 0.444 . . . . 1.28 111.741 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.9 ttt180 -93.64 -32.0 14.25 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.35 0.406 . . . . 1.78 110.896 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.13 -41.58 12.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.168 -0.469 . . . . 1.5 111.426 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 . . . . . 0 N--CA 1.466 0.337 0 O-C-N 123.418 0.449 . . . . 1.31 111.07 179.81 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 CA--C 1.544 0.75 0 CA-C-O 118.69 -0.672 . . . . 1.5 112.167 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.35 -3.12 12.79 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.284 1.99 . . . . 0.92 113.554 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' TRP . . . -74.29 -39.29 63.04 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.617 0.367 . . . . 0.88 111.661 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.87 -34.09 57.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.111 -0.495 . . . . 1.23 111.194 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -70.88 -40.58 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 116.068 -0.514 . . . . 0.64 110.056 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.6 m -74.35 -26.02 59.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.745 -0.661 . . . . 0.88 111.087 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -76.07 -38.11 57.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.972 -0.558 . . . . 1.24 111.086 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -77.02 -31.07 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.274 -0.421 . . . . 1.33 111.022 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -75.85 -34.04 60.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.981 -0.554 . . . . 1.58 111.022 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 80.3 mtt180 -80.48 -26.79 38.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.062 -0.517 . . . . 2.06 111.272 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 31.7 tttm -85.98 -20.49 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.485 0.491 . . . . 1.28 111.041 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.9 ttt180 -94.33 -31.02 14.22 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.36 0.412 . . . . 1.78 111.034 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -90.64 -43.56 10.08 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.327 0.392 . . . . 1.5 111.543 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.7 mt-30 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.31 111.146 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.1 mp . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 118.628 -0.701 . . . . 1.5 112.489 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.94 -7.71 19.42 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.396 2.064 . . . . 0.92 114.162 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.67 -42.19 61.67 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.483 0.313 . . . . 0.88 111.521 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.33 -34.21 63.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.083 -0.508 . . . . 1.23 111.048 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 13' ' ' LEU . 6.4 mm -69.99 -38.24 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.868 -0.606 . . . . 0.64 109.984 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.8 m -74.47 -27.79 60.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.757 -0.656 . . . . 0.88 111.242 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -75.22 -38.48 60.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 1.24 111.202 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.2 pp -76.45 -31.16 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.192 -0.458 . . . . 1.33 111.103 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -75.85 -33.18 60.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.939 -0.573 . . . . 1.58 111.113 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.69 -26.28 37.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.038 -0.528 . . . . 2.06 111.077 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -85.78 -21.63 28.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.065 -0.516 . . . . 1.28 111.413 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 24.9 ttt180 -93.75 -32.77 13.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.145 -0.48 . . . . 1.78 111.209 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.28 -43.55 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.349 0.405 . . . . 1.5 111.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.6 mt-30 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.007 0.432 . . . . 1.31 111.131 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.1 tp . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 118.811 -0.614 . . . . 1.5 111.845 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.99 -10.41 15.3 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.437 2.091 . . . . 0.92 113.743 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -41.85 67.28 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.022 0.378 . . . . 0.88 112.022 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.01 -35.69 69.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.331 -0.395 . . . . 1.23 111.355 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.4 mm -70.56 -39.53 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 123.658 0.599 . . . . 0.64 110.463 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -72.56 -31.5 65.3 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.025 -0.534 . . . . 0.88 111.549 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.72 -37.37 62.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.203 -0.453 . . . . 1.24 111.415 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.4 pp -75.9 -33.68 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.273 0.358 . . . . 1.33 111.323 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.61 -35.01 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.486 0.491 . . . . 1.58 111.232 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -78.8 -27.97 44.49 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.532 0.52 . . . . 2.06 111.506 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -86.41 -19.87 29.04 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.39 0.431 . . . . 1.28 111.593 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.5 ttt180 -92.98 -31.64 14.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.332 0.395 . . . . 1.78 110.909 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -89.78 -41.36 11.91 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.418 0.448 . . . . 1.5 111.361 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 . . . . . 0 N--CA 1.465 0.312 0 O-C-N 123.376 0.423 . . . . 1.31 110.992 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.629 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.463 -0.255 . . . . 2.35 112.463 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.4 tp -62.92 -37.22 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 122.958 0.503 . . . . 2.45 111.743 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.73 -28.94 66.18 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.148 -0.478 . . . . 1.23 112.896 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.17 -43.29 43.38 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.581 0.352 . . . . 1.37 111.179 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.2 m -73.74 -22.7 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.403 -0.362 . . . . 1.28 111.666 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 9.2 tp -84.42 -39.95 18.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.121 -0.49 . . . . 1.13 111.325 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -84.69 -11.42 55.9 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.844 0.683 . . . . 1.59 112.844 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.42 -36.05 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 122.903 0.127 . . . . 1.09 111.331 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 5.2 mt -107.15 -34.4 7.15 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.59 0.589 . . . . 1.19 112.59 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -93.0 36.22 1.04 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.968 0.413 . . . . 1.05 111.382 -179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -140.05 -46.11 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.976 -0.556 . . . . 1.51 111.487 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.66 94.51 0.82 Allowed Glycine 0 C--N 1.338 0.689 0 O-C-N 123.541 0.525 . . . . 0.98 112.541 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.3 mp -105.99 -46.86 0.13 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 118.673 -0.679 . . . . 1.5 112.306 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.28 -12.07 31.25 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.275 1.983 . . . . 0.92 113.779 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' O ' ' HD1' ' A' ' 19' ' ' TRP . . . -72.72 -40.73 65.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.457 0.303 . . . . 0.88 111.472 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.43 -34.82 68.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.173 -0.467 . . . . 1.23 110.908 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -69.91 -35.77 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.793 -0.64 . . . . 0.64 109.99 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.4 m -74.62 -30.39 61.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.659 -0.7 . . . . 0.88 111.251 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.401 ' HD1' ' O ' ' A' ' 15' ' ' ALA . 15.1 m95 -74.6 -37.81 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.286 -0.416 . . . . 1.24 111.23 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 pp -76.03 -30.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 116.341 -0.39 . . . . 1.33 111.134 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -76.36 -32.57 58.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.011 -0.54 . . . . 1.58 111.058 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.9 mtt180 -80.97 -26.38 36.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.174 -0.467 . . . . 2.06 111.096 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.26 -23.87 28.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.094 -0.503 . . . . 1.28 111.232 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.1 ttt180 -91.06 -31.26 16.34 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.534 0.521 . . . . 1.78 111.304 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.39 -44.44 9.65 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.257 0.348 . . . . 1.5 111.358 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 53.5 mt-30 -100.03 -50.49 3.97 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.396 0.435 . . . . 1.31 111.075 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.134 0 CA-C-N 116.067 -0.515 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.437 -0.265 . . . . 2.35 112.437 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.527 ' H ' HD12 ' A' ' 2' ' ' ILE . 1.2 mp -65.35 -40.41 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.836 0.454 . . . . 2.45 111.1 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.0 -33.81 70.29 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.486 0.491 . . . . 1.23 113.236 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.531 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -72.87 -48.76 34.71 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.588 0.355 . . . . 1.37 111.37 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 1' ' ' GLY . 25.2 t -66.73 -28.46 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.485 -0.325 . . . . 1.28 110.517 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 7.9 tp -76.06 -39.43 55.48 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.364 -0.38 . . . . 1.13 111.2 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -74.91 -22.86 58.36 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.217 0.451 . . . . 1.59 112.217 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 4' ' ' ALA . 48.4 t -91.4 -21.84 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 110.079 -0.341 . . . . 1.09 110.079 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.6 mp -93.67 -11.31 31.89 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.133 0.42 . . . . 1.19 112.133 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 p -90.21 -29.58 18.12 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.146 0.424 . . . . 1.05 112.146 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -90.9 -46.73 8.01 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.222 0.326 . . . . 1.51 111.732 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.15 97.35 1.74 Allowed Glycine 0 C--N 1.339 0.696 0 O-C-N 123.421 0.451 . . . . 0.98 112.557 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -125.34 -48.58 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 118.7 -0.667 . . . . 1.5 111.647 179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.4 Cg_exo -78.98 -5.62 14.64 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.395 2.064 . . . . 0.92 113.325 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.61 67.94 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 122.712 0.405 . . . . 0.88 111.911 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tp -72.76 -35.42 67.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 1.23 110.951 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mm -71.01 -36.7 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.856 -0.611 . . . . 0.64 110.14 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -74.6 -29.81 61.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.85 -0.614 . . . . 0.88 111.388 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -75.75 -36.91 59.74 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.421 0.45 . . . . 1.24 111.204 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -76.31 -31.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.301 -0.409 . . . . 1.33 110.947 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -75.96 -34.16 59.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.937 -0.574 . . . . 1.58 111.061 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 73.5 mtt180 -80.17 -25.62 39.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.173 -0.467 . . . . 2.06 111.272 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.63 -24.97 26.9 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.256 -0.429 . . . . 1.28 111.33 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.7 ttt180 -90.8 -30.43 17.0 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.463 0.477 . . . . 1.78 111.387 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -92.29 -43.53 9.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.271 0.357 . . . . 1.5 111.45 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.8 mt-30 -102.61 -50.45 3.56 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.407 0.442 . . . . 1.31 111.016 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.096 -0.502 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.627 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 112.647 -0.181 . . . . 2.35 112.647 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 mt -66.74 -44.03 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.944 0.498 . . . . 2.45 110.875 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.17 -26.5 74.17 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.01 -0.541 . . . . 1.23 113.005 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.12 -44.92 28.68 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.604 0.362 . . . . 1.37 111.112 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 1' ' ' GLY . 13.1 m -73.17 -21.72 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 123.263 0.352 . . . . 1.28 111.491 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tt -85.74 -32.6 21.78 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.165 -0.47 . . . . 1.13 110.772 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -84.87 -15.17 45.55 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.129 -0.487 . . . . 1.59 112.273 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.16 -36.79 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 O-C-N 122.975 0.172 . . . . 1.09 111.06 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 6.3 mp -96.41 -40.35 9.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.78 0.289 . . . . 1.19 111.78 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -95.59 73.07 3.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.41 0.624 . . . . 1.05 110.685 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -149.76 -46.17 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.239 -0.891 . . . . 1.51 110.898 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.8 101.77 0.37 Allowed Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.989 -0.55 . . . . 0.98 112.236 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.6 mp -94.95 -38.59 0.29 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.608 -0.711 . . . . 1.5 112.728 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.25 -13.09 38.35 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.214 1.942 . . . . 0.92 113.886 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.06 -42.5 63.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.26 0.35 . . . . 0.88 111.604 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.7 -33.64 64.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.274 -0.421 . . . . 1.23 111.388 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 13' ' ' LEU . 11.5 mm -70.91 -38.58 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 123.518 0.511 . . . . 0.64 110.108 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.5 m -73.94 -30.22 62.44 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.873 -0.603 . . . . 0.88 111.409 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -75.16 -37.34 61.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.22 -0.446 . . . . 1.24 111.259 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.85 -31.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 116.426 -0.352 . . . . 1.33 111.049 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -76.4 -32.63 58.65 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.006 -0.543 . . . . 1.58 111.115 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.4 mtt180 -80.97 -26.01 36.9 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.139 -0.482 . . . . 2.06 111.221 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -86.5 -23.91 25.75 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.43 0.456 . . . . 1.28 111.356 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 25.0 ttt180 -90.4 -33.26 16.1 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.449 0.468 . . . . 1.78 111.117 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -89.29 -42.12 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.368 0.417 . . . . 1.5 111.421 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.5 mt-30 -105.19 -50.6 3.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.929 0.395 . . . . 1.31 111.052 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.5 -0.24 . . . . 2.35 112.5 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.2 tp -60.81 -36.29 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.092 0.557 . . . . 2.45 111.861 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -71.22 -32.74 65.22 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.984 -0.553 . . . . 1.23 113.437 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.57 -45.81 28.87 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.493 0.317 . . . . 1.37 111.38 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.7 m -65.17 -37.09 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 116.317 -0.401 . . . . 1.28 111.355 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.81 -38.17 64.68 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.763 -0.653 . . . . 1.13 111.157 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 27.1 tttp -74.54 -11.66 60.27 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.284 0.365 . . . . 1.59 111.747 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -110.46 -7.19 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.202 0.314 . . . . 1.09 111.552 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -107.6 -41.39 5.05 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.579 0.585 . . . . 1.19 112.579 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 43.3 p -84.78 1.07 48.4 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.573 0.583 . . . . 1.05 112.573 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.9 p -95.47 -44.52 7.49 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.667 -0.242 . . . . 1.51 111.57 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.63 115.6 3.55 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 123.457 0.473 . . . . 0.98 112.604 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.512 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 4.1 mp -128.98 -45.81 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.619 -0.705 . . . . 1.5 112.187 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.512 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 8.3 Cg_exo -73.34 -7.13 19.99 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.312 2.008 . . . . 0.92 113.284 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.53 59.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.663 0.385 . . . . 0.88 111.675 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.8 -33.09 60.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.182 -0.463 . . . . 1.23 111.103 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 13' ' ' LEU . 7.9 mm -71.91 -40.75 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.914 -0.585 . . . . 0.64 110.086 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.1 m -74.13 -26.63 60.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.812 -0.631 . . . . 0.88 111.075 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m95 -76.08 -37.71 57.87 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.032 -0.531 . . . . 1.24 111.194 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' ILE . 2.3 pp -77.1 -31.35 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.369 0.418 . . . . 1.33 111.131 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.89 -34.31 59.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.932 -0.576 . . . . 1.58 111.032 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.95 -24.61 38.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.561 . . . . 2.06 111.295 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 29.0 tttm -86.55 -23.63 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.459 0.474 . . . . 1.28 110.913 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -90.7 -33.81 15.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.109 -0.496 . . . . 1.78 111.39 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -89.37 -42.56 11.47 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.418 0.448 . . . . 1.5 111.638 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 55.2 mt-30 -104.64 -50.16 3.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.968 0.413 . . . . 1.31 111.075 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.598 -0.201 . . . . 2.35 112.598 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp -62.27 -39.53 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.992 0.517 . . . . 2.45 112.327 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -70.41 -31.38 68.5 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.015 -0.538 . . . . 1.23 113.076 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.622 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -74.97 -45.73 40.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 122.648 0.379 . . . . 1.37 111.354 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.3 m -65.85 -38.62 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 123.392 0.433 . . . . 1.28 111.484 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 2' ' ' ILE . 12.9 mt -73.22 -30.17 63.31 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.984 -0.553 . . . . 1.13 111.179 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -71.93 -36.28 69.9 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.487 0.492 . . . . 1.59 111.5 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 4' ' ' ALA . 7.9 m -87.45 -15.61 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 123.376 0.423 . . . . 1.09 112.089 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -92.94 -23.2 18.81 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.325 0.391 . . . . 1.19 112.019 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.0 p -87.44 -1.05 57.66 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.36 0.504 . . . . 1.05 112.36 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -110.6 -46.16 3.42 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.914 0.338 . . . . 1.51 111.914 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.64 110.62 4.07 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 121.408 -0.425 . . . . 0.98 112.886 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.531 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 1.8 tp -138.72 -46.78 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.735 -0.65 . . . . 1.5 111.922 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.5 Cg_exo -78.87 -10.55 15.43 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.449 2.099 . . . . 0.92 113.661 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -42.55 67.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.647 0.379 . . . . 0.88 111.998 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.99 -35.55 69.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.404 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.2 mm -70.4 -38.69 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 123.599 0.562 . . . . 0.64 110.468 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -72.75 -32.36 65.6 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.952 -0.567 . . . . 0.88 111.398 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -73.9 -38.05 64.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.186 -0.461 . . . . 1.24 111.519 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.28 -34.04 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.274 0.359 . . . . 1.33 111.481 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.53 -35.43 63.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.195 -0.457 . . . . 1.58 111.413 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 94.4 mtt180 -78.54 -28.53 46.08 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.153 -0.476 . . . . 2.06 111.489 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -85.47 -20.53 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.361 -0.382 . . . . 1.28 111.666 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 31.3 ttt180 -92.43 -31.13 15.4 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.38 0.425 . . . . 1.78 110.989 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.38 -41.37 12.16 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.427 0.454 . . . . 1.5 111.398 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 52.7 mt-30 -106.37 -49.6 3.31 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.43 0.456 . . . . 1.31 111.075 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.092 -0.504 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.471 -0.252 . . . . 2.35 112.471 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp -63.11 -40.08 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 122.796 0.438 . . . . 2.45 112.069 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -70.49 -32.43 67.9 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.961 -0.563 . . . . 1.23 113.032 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -72.55 -47.32 49.19 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.528 0.331 . . . . 1.37 111.23 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 1' ' ' GLY . 5.9 m -66.2 -36.02 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 123.365 0.416 . . . . 1.28 111.598 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.71 -32.49 65.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.126 -0.488 . . . . 1.13 111.456 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.6 -33.23 64.5 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.439 0.462 . . . . 1.59 111.853 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 4' ' ' ALA . 8.4 m -90.48 -9.75 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.004 0.372 . . . . 1.09 112.004 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 5.3 tp -99.26 -26.8 14.05 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.22 0.325 . . . . 1.19 111.701 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p -84.45 -7.01 59.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.383 0.512 . . . . 1.05 112.383 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -102.94 -45.86 4.84 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.149 0.28 . . . . 1.51 111.729 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.35 108.14 3.56 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 121.38 -0.438 . . . . 0.98 112.862 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.5 tp -136.38 -46.63 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 CA-C-O 118.768 -0.634 . . . . 1.5 111.782 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.6 Cg_exo -78.89 -10.77 15.36 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.518 2.146 . . . . 0.92 113.64 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.7 66.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.906 0.336 . . . . 0.88 111.906 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.52 -35.63 70.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.324 -0.398 . . . . 1.23 111.255 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.3 mm -70.92 -39.5 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.836 -0.62 . . . . 0.64 110.614 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -72.86 -31.25 64.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.041 -0.527 . . . . 0.88 111.51 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.83 -37.58 62.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.127 -0.488 . . . . 1.24 111.398 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.51 -33.55 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 123.294 0.371 . . . . 1.33 111.315 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -74.92 -34.92 62.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.503 0.502 . . . . 1.58 111.339 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -78.78 -28.39 44.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.079 -0.51 . . . . 2.06 111.439 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -85.99 -19.28 30.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.328 0.392 . . . . 1.28 111.665 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 36.1 ttt180 -93.34 -31.68 14.58 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.349 0.406 . . . . 1.78 110.915 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -89.39 -40.96 12.39 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.422 0.452 . . . . 1.5 111.388 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -109.47 -50.63 2.97 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.41 0.444 . . . . 1.31 111.061 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.084 -0.507 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.602 -0.199 . . . . 2.35 112.602 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp -60.59 -37.92 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 112.378 0.51 . . . . 2.45 112.378 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.47 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -70.26 -35.26 69.77 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.021 -0.536 . . . . 1.23 113.027 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -71.86 -46.42 58.0 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 122.564 0.346 . . . . 1.37 111.379 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 1' ' ' GLY . 3.9 m -66.12 -36.7 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 123.379 0.425 . . . . 1.28 111.627 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.3 -32.44 66.58 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.474 0.484 . . . . 1.13 111.407 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -73.9 -33.24 63.93 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.398 0.436 . . . . 1.59 111.999 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 4' ' ' ALA . 9.2 m -89.71 -11.09 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.024 0.379 . . . . 1.09 112.024 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.7 tp -97.82 -27.8 14.15 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.266 0.353 . . . . 1.19 111.715 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 p -84.16 -10.84 57.43 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.575 0.584 . . . . 1.05 112.575 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 p -99.14 -45.46 5.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.246 0.341 . . . . 1.51 111.748 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.23 107.5 3.41 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 123.453 0.471 . . . . 0.98 112.788 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.538 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 tp -136.04 -46.54 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.733 -0.651 . . . . 1.5 111.773 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.0 Cg_exo -78.95 -11.44 15.06 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.437 2.091 . . . . 0.92 113.66 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.55 69.52 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.004 0.372 . . . . 0.88 112.004 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -72.28 -36.26 68.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.291 -0.413 . . . . 1.23 111.298 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -70.47 -38.92 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 123.624 0.578 . . . . 0.64 110.541 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.0 m -73.0 -31.89 64.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.88 111.482 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -74.58 -37.26 62.96 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.134 -0.485 . . . . 1.24 111.492 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.73 -33.6 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 123.3 0.375 . . . . 1.33 111.309 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.84 -34.58 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.51 0.506 . . . . 1.58 111.324 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.83 -28.65 44.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 2.06 111.379 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -86.01 -18.82 31.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.411 0.444 . . . . 1.28 111.741 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.9 ttt180 -93.64 -32.0 14.25 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.35 0.406 . . . . 1.78 110.896 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.13 -41.58 12.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.168 -0.469 . . . . 1.5 111.426 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -109.16 -50.37 3.01 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.418 0.449 . . . . 1.31 111.07 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.081 -0.509 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.621 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.541 -0.224 . . . . 2.35 112.541 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.2 pp -62.11 -37.08 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 122.935 0.494 . . . . 2.45 112.283 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -71.18 -31.9 66.01 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.952 -0.567 . . . . 1.23 113.108 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.02 -45.1 36.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 122.58 0.352 . . . . 1.37 111.597 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 1' ' ' GLY . 5.2 m -69.71 -34.19 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 123.31 0.382 . . . . 1.28 111.882 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tt -75.7 -41.52 53.4 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.132 -0.485 . . . . 1.13 111.065 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.8 tttp -73.76 -17.94 61.04 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.19 0.441 . . . . 1.59 112.19 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 5' ' ' VAL . 5.4 p -97.57 -23.37 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 O-C-N 123.246 0.341 . . . . 1.09 111.519 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -89.59 -39.11 13.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.322 0.49 . . . . 1.19 112.322 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.5 p -87.76 53.32 2.73 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.425 0.631 . . . . 1.05 111.318 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 p -141.53 -45.16 0.36 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.413 -0.812 . . . . 1.51 111.014 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.75 87.5 0.32 Allowed Glycine 0 C--N 1.34 0.771 0 O-C-N 123.52 0.512 . . . . 0.98 112.209 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.15 -44.74 0.35 Allowed Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 118.69 -0.672 . . . . 1.5 112.167 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.35 -3.12 12.79 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.284 1.99 . . . . 0.92 113.554 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' TRP . . . -74.29 -39.29 63.04 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.617 0.367 . . . . 0.88 111.661 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.87 -34.09 57.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.111 -0.495 . . . . 1.23 111.194 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -70.88 -40.58 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 116.068 -0.514 . . . . 0.64 110.056 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.6 m -74.35 -26.02 59.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.745 -0.661 . . . . 0.88 111.087 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -76.07 -38.11 57.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.972 -0.558 . . . . 1.24 111.086 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -77.02 -31.07 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.274 -0.421 . . . . 1.33 111.022 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -75.85 -34.04 60.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.981 -0.554 . . . . 1.58 111.022 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 80.3 mtt180 -80.48 -26.79 38.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.062 -0.517 . . . . 2.06 111.272 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 31.7 tttm -85.98 -20.49 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.485 0.491 . . . . 1.28 111.041 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.9 ttt180 -94.33 -31.02 14.22 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.36 0.412 . . . . 1.78 111.034 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -90.64 -43.56 10.08 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.327 0.392 . . . . 1.5 111.543 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.7 mt-30 -99.44 -50.59 4.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.31 111.146 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 116.094 -0.503 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 112.765 -0.134 . . . . 2.35 112.765 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pt -62.92 -42.11 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.027 0.531 . . . . 2.45 112.154 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -70.61 -28.06 71.57 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.84 -0.618 . . . . 1.23 113.23 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.7 31.86 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.581 0.352 . . . . 1.37 111.383 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 1' ' ' GLY . 8.6 m -73.18 -24.35 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 116.491 -0.322 . . . . 1.28 111.642 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.448 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 4.0 tp -84.34 -39.1 19.53 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.222 -0.445 . . . . 1.13 111.282 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 2.5 tptp -81.21 -18.51 45.89 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.817 0.673 . . . . 1.59 112.817 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.7 t -106.46 -42.75 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 122.961 0.163 . . . . 1.09 111.387 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.44 -35.29 13.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.261 0.467 . . . . 1.19 112.261 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -95.71 64.18 2.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.456 0.646 . . . . 1.05 110.656 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.9 p -145.55 -45.05 0.21 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.176 -0.92 . . . . 1.51 110.991 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.39 112.5 1.36 Allowed Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.019 -0.537 . . . . 0.98 112.305 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.1 mp -103.67 -44.7 0.18 Allowed Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.628 -0.701 . . . . 1.5 112.489 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.94 -7.71 19.42 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.396 2.064 . . . . 0.92 114.162 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.67 -42.19 61.67 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.483 0.313 . . . . 0.88 111.521 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.33 -34.21 63.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.083 -0.508 . . . . 1.23 111.048 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 13' ' ' LEU . 6.4 mm -69.99 -38.24 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.868 -0.606 . . . . 0.64 109.984 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.8 m -74.47 -27.79 60.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.757 -0.656 . . . . 0.88 111.242 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -75.22 -38.48 60.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 1.24 111.202 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.2 pp -76.45 -31.16 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.192 -0.458 . . . . 1.33 111.103 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -75.85 -33.18 60.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.939 -0.573 . . . . 1.58 111.113 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.69 -26.28 37.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.038 -0.528 . . . . 2.06 111.077 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -85.78 -21.63 28.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.065 -0.516 . . . . 1.28 111.413 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 24.9 ttt180 -93.75 -32.77 13.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.145 -0.48 . . . . 1.78 111.209 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.28 -43.55 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.349 0.405 . . . . 1.5 111.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.6 mt-30 -102.26 -50.52 3.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.007 0.432 . . . . 1.31 111.131 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 116.102 -0.499 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.621 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.478 -0.249 . . . . 2.35 112.478 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp -63.45 -37.69 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.407 0.521 . . . . 2.45 112.407 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -70.82 -32.23 66.83 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 116.012 -0.54 . . . . 1.23 112.873 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -74.77 -47.66 29.73 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.575 0.35 . . . . 1.37 111.367 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.6 m -65.12 -36.58 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.324 0.39 . . . . 1.28 111.447 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 2' ' ' ILE . 9.0 mt -74.13 -29.55 61.87 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.157 -0.474 . . . . 1.13 111.142 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -72.66 -34.24 67.11 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.442 0.464 . . . . 1.59 111.569 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 4' ' ' ALA . 5.6 m -91.25 -9.97 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.115 0.413 . . . . 1.09 112.115 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.2 tp -97.78 -27.28 14.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.225 0.328 . . . . 1.19 111.686 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.3 p -85.17 -6.45 59.28 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.432 0.53 . . . . 1.05 112.432 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.6 p -103.49 -45.88 4.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.798 0.296 . . . . 1.51 111.798 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.19 109.81 3.85 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 121.374 -0.441 . . . . 0.98 112.913 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.538 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 tp -136.55 -46.56 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.811 -0.614 . . . . 1.5 111.845 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.3 Cg_exo -78.99 -10.41 15.3 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.437 2.091 . . . . 0.92 113.743 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -41.85 67.28 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.022 0.378 . . . . 0.88 112.022 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.01 -35.69 69.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.331 -0.395 . . . . 1.23 111.355 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.4 mm -70.56 -39.53 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 123.658 0.599 . . . . 0.64 110.463 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -72.56 -31.5 65.3 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.025 -0.534 . . . . 0.88 111.549 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.72 -37.37 62.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.203 -0.453 . . . . 1.24 111.415 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.4 pp -75.9 -33.68 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.273 0.358 . . . . 1.33 111.323 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.61 -35.01 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.486 0.491 . . . . 1.58 111.232 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -78.8 -27.97 44.49 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.532 0.52 . . . . 2.06 111.506 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -86.41 -19.87 29.04 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.39 0.431 . . . . 1.28 111.593 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.5 ttt180 -92.98 -31.64 14.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.332 0.395 . . . . 1.78 110.909 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -89.78 -41.36 11.91 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.418 0.448 . . . . 1.5 111.361 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -108.81 -50.71 2.98 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.376 0.423 . . . . 1.31 110.992 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.126 -0.488 . . . . 0.84 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.3 mp . . . . . 0 CA--C 1.545 0.784 0 CA-C-O 118.673 -0.679 . . . . 1.5 112.306 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.28 -12.07 31.25 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.275 1.983 . . . . 0.92000000000000004 113.779 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' O ' ' HD1' ' A' ' 19' ' ' TRP . . . -72.72 -40.73 65.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.457 0.303 . . . . 0.88 111.472 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.43 -34.82 68.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.173 -0.467 . . . . 1.23 110.908 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -69.91 -35.77 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.793 -0.64 . . . . 0.64000000000000001 109.99 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.4 m -74.62 -30.39 61.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.659 -0.7 . . . . 0.88 111.251 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.401 ' HD1' ' O ' ' A' ' 15' ' ' ALA . 15.1 m95 -74.6 -37.81 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.286 -0.416 . . . . 1.24 111.23 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 pp -76.03 -30.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 116.341 -0.39 . . . . 1.3300000000000001 111.134 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -76.36 -32.57 58.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.011 -0.54 . . . . 1.5800000000000001 111.058 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.9 mtt180 -80.97 -26.38 36.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.174 -0.467 . . . . 2.0600000000000001 111.096 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.26 -23.87 28.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.094 -0.503 . . . . 1.28 111.232 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.1 ttt180 -91.06 -31.26 16.34 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.534 0.521 . . . . 1.78 111.304 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.39 -44.44 9.65 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.257 0.348 . . . . 1.5 111.358 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 53.5 mt-30 . . . . . 0 N--CA 1.466 0.359 0 O-C-N 123.396 0.435 . . . . 1.3100000000000001 111.075 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 118.7 -0.667 . . . . 1.5 111.647 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.98 -5.62 14.64 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.395 2.064 . . . . 0.92000000000000004 113.325 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.61 67.94 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 122.712 0.405 . . . . 0.88 111.911 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tp -72.76 -35.42 67.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 1.23 110.951 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mm -71.01 -36.7 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.856 -0.611 . . . . 0.64000000000000001 110.14 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -74.6 -29.81 61.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.85 -0.614 . . . . 0.88 111.388 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -75.75 -36.91 59.74 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.421 0.45 . . . . 1.24 111.204 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -76.31 -31.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.301 -0.409 . . . . 1.3300000000000001 110.947 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -75.96 -34.16 59.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.937 -0.574 . . . . 1.5800000000000001 111.061 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 73.5 mtt180 -80.17 -25.62 39.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.173 -0.467 . . . . 2.0600000000000001 111.272 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.63 -24.97 26.9 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.256 -0.429 . . . . 1.28 111.33 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.7 ttt180 -90.8 -30.43 17.0 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.463 0.477 . . . . 1.78 111.387 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -92.29 -43.53 9.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.271 0.357 . . . . 1.5 111.45 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.8 mt-30 . . . . . 0 N--CA 1.465 0.323 0 O-C-N 123.407 0.442 . . . . 1.3100000000000001 111.016 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.6 mp . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 118.608 -0.711 . . . . 1.5 112.728 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.25 -13.09 38.35 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.214 1.942 . . . . 0.92000000000000004 113.886 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.06 -42.5 63.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.26 0.35 . . . . 0.88 111.604 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.7 -33.64 64.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.274 -0.421 . . . . 1.23 111.388 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 13' ' ' LEU . 11.5 mm -70.91 -38.58 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 123.518 0.511 . . . . 0.64000000000000001 110.108 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.5 m -73.94 -30.22 62.44 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.873 -0.603 . . . . 0.88 111.409 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -75.16 -37.34 61.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.22 -0.446 . . . . 1.24 111.259 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.85 -31.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 116.426 -0.352 . . . . 1.3300000000000001 111.049 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -76.4 -32.63 58.65 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.006 -0.543 . . . . 1.5800000000000001 111.115 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.4 mtt180 -80.97 -26.01 36.9 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.139 -0.482 . . . . 2.0600000000000001 111.221 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -86.5 -23.91 25.75 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.43 0.456 . . . . 1.28 111.356 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 25.0 ttt180 -90.4 -33.26 16.1 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.449 0.468 . . . . 1.78 111.117 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -89.29 -42.12 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.368 0.417 . . . . 1.5 111.421 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.5 mt-30 . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.929 0.395 . . . . 1.3100000000000001 111.052 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' HG12 ' A' ' 17' ' ' ILE . 4.1 mp . . . . . 0 CA--C 1.544 0.734 0 CA-C-O 118.619 -0.705 . . . . 1.5 112.187 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.34 -7.13 19.99 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.312 2.008 . . . . 0.92000000000000004 113.284 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.53 59.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.663 0.385 . . . . 0.88 111.675 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.8 -33.09 60.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.182 -0.463 . . . . 1.23 111.103 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 13' ' ' LEU . 7.9 mm -71.91 -40.75 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.914 -0.585 . . . . 0.64000000000000001 110.086 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.1 m -74.13 -26.63 60.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.812 -0.631 . . . . 0.88 111.075 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m95 -76.08 -37.71 57.87 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.032 -0.531 . . . . 1.24 111.194 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' ILE . 2.3 pp -77.1 -31.35 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.369 0.418 . . . . 1.3300000000000001 111.131 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.89 -34.31 59.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.932 -0.576 . . . . 1.5800000000000001 111.032 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.95 -24.61 38.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.561 . . . . 2.0600000000000001 111.295 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 29.0 tttm -86.55 -23.63 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.459 0.474 . . . . 1.28 110.913 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -90.7 -33.81 15.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.109 -0.496 . . . . 1.78 111.39 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -89.37 -42.56 11.47 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.418 0.448 . . . . 1.5 111.638 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 55.2 mt-30 . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.968 0.413 . . . . 1.3100000000000001 111.075 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.8 tp . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 118.735 -0.65 . . . . 1.5 111.922 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.87 -10.55 15.43 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.449 2.099 . . . . 0.92000000000000004 113.661 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -42.55 67.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.647 0.379 . . . . 0.88 111.998 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.99 -35.55 69.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.404 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.2 mm -70.4 -38.69 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 123.599 0.562 . . . . 0.64000000000000001 110.468 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -72.75 -32.36 65.6 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.952 -0.567 . . . . 0.88 111.398 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -73.9 -38.05 64.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.186 -0.461 . . . . 1.24 111.519 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.28 -34.04 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.274 0.359 . . . . 1.3300000000000001 111.481 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.53 -35.43 63.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.195 -0.457 . . . . 1.5800000000000001 111.413 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 94.4 mtt180 -78.54 -28.53 46.08 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.153 -0.476 . . . . 2.0600000000000001 111.489 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -85.47 -20.53 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.361 -0.382 . . . . 1.28 111.666 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 31.3 ttt180 -92.43 -31.13 15.4 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.38 0.425 . . . . 1.78 110.989 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.38 -41.37 12.16 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.427 0.454 . . . . 1.5 111.398 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 52.7 mt-30 . . . . . 0 N--CA 1.465 0.299 0 O-C-N 123.43 0.456 . . . . 1.3100000000000001 111.075 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.5 tp . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 118.768 -0.634 . . . . 1.5 111.782 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.89 -10.77 15.36 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.518 2.146 . . . . 0.92000000000000004 113.64 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.7 66.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.906 0.336 . . . . 0.88 111.906 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.52 -35.63 70.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.324 -0.398 . . . . 1.23 111.255 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.3 mm -70.92 -39.5 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.836 -0.62 . . . . 0.64000000000000001 110.614 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -72.86 -31.25 64.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.041 -0.527 . . . . 0.88 111.51 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.83 -37.58 62.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.127 -0.488 . . . . 1.24 111.398 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.51 -33.55 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 123.294 0.371 . . . . 1.3300000000000001 111.315 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -74.92 -34.92 62.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.503 0.502 . . . . 1.5800000000000001 111.339 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -78.78 -28.39 44.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.079 -0.51 . . . . 2.0600000000000001 111.439 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -85.99 -19.28 30.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.328 0.392 . . . . 1.28 111.665 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 36.1 ttt180 -93.34 -31.68 14.58 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.349 0.406 . . . . 1.78 110.915 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -89.39 -40.96 12.39 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.422 0.452 . . . . 1.5 111.388 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 . . . . . 0 N--CA 1.466 0.326 0 O-C-N 123.41 0.444 . . . . 1.3100000000000001 111.061 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.1 tp . . . . . 0 CA--C 1.545 0.785 0 CA-C-O 118.733 -0.651 . . . . 1.5 111.773 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.95 -11.44 15.06 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.437 2.091 . . . . 0.92000000000000004 113.66 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.55 69.52 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.004 0.372 . . . . 0.88 112.004 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -72.28 -36.26 68.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.291 -0.413 . . . . 1.23 111.298 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -70.47 -38.92 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 123.624 0.578 . . . . 0.64000000000000001 110.541 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.0 m -73.0 -31.89 64.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.88 111.482 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -74.58 -37.26 62.96 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.134 -0.485 . . . . 1.24 111.492 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.73 -33.6 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 123.3 0.375 . . . . 1.3300000000000001 111.309 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.84 -34.58 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.51 0.506 . . . . 1.5800000000000001 111.324 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.83 -28.65 44.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 2.0600000000000001 111.379 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -86.01 -18.82 31.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.411 0.444 . . . . 1.28 111.741 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.9 ttt180 -93.64 -32.0 14.25 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.35 0.406 . . . . 1.78 110.896 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.13 -41.58 12.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.168 -0.469 . . . . 1.5 111.426 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 . . . . . 0 N--CA 1.466 0.337 0 O-C-N 123.418 0.449 . . . . 1.3100000000000001 111.07 179.81 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 CA--C 1.544 0.75 0 CA-C-O 118.69 -0.672 . . . . 1.5 112.167 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.35 -3.12 12.79 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.284 1.99 . . . . 0.92000000000000004 113.554 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' TRP . . . -74.29 -39.29 63.04 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.617 0.367 . . . . 0.88 111.661 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.87 -34.09 57.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.111 -0.495 . . . . 1.23 111.194 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -70.88 -40.58 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 116.068 -0.514 . . . . 0.64000000000000001 110.056 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.6 m -74.35 -26.02 59.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.745 -0.661 . . . . 0.88 111.087 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -76.07 -38.11 57.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.972 -0.558 . . . . 1.24 111.086 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -77.02 -31.07 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.274 -0.421 . . . . 1.3300000000000001 111.022 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -75.85 -34.04 60.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.981 -0.554 . . . . 1.5800000000000001 111.022 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 80.3 mtt180 -80.48 -26.79 38.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.062 -0.517 . . . . 2.0600000000000001 111.272 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 31.7 tttm -85.98 -20.49 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.485 0.491 . . . . 1.28 111.041 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.9 ttt180 -94.33 -31.02 14.22 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.36 0.412 . . . . 1.78 111.034 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -90.64 -43.56 10.08 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.327 0.392 . . . . 1.5 111.543 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.7 mt-30 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.3100000000000001 111.146 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.1 mp . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 118.628 -0.701 . . . . 1.5 112.489 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.94 -7.71 19.42 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.396 2.064 . . . . 0.92000000000000004 114.162 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.67 -42.19 61.67 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.483 0.313 . . . . 0.88 111.521 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.33 -34.21 63.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.083 -0.508 . . . . 1.23 111.048 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 13' ' ' LEU . 6.4 mm -69.99 -38.24 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.868 -0.606 . . . . 0.64000000000000001 109.984 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.8 m -74.47 -27.79 60.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.757 -0.656 . . . . 0.88 111.242 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -75.22 -38.48 60.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 1.24 111.202 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.2 pp -76.45 -31.16 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.192 -0.458 . . . . 1.3300000000000001 111.103 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -75.85 -33.18 60.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.939 -0.573 . . . . 1.5800000000000001 111.113 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.69 -26.28 37.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.038 -0.528 . . . . 2.0600000000000001 111.077 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -85.78 -21.63 28.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.065 -0.516 . . . . 1.28 111.413 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 24.9 ttt180 -93.75 -32.77 13.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.145 -0.48 . . . . 1.78 111.209 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.28 -43.55 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.349 0.405 . . . . 1.5 111.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.6 mt-30 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.007 0.432 . . . . 1.3100000000000001 111.131 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 17' ' ' ILE . 2.1 tp . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 118.811 -0.614 . . . . 1.5 111.845 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.99 -10.41 15.3 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.437 2.091 . . . . 0.92000000000000004 113.743 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -41.85 67.28 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.022 0.378 . . . . 0.88 112.022 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.01 -35.69 69.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.331 -0.395 . . . . 1.23 111.355 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.4 mm -70.56 -39.53 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 123.658 0.599 . . . . 0.64000000000000001 110.463 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -72.56 -31.5 65.3 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.025 -0.534 . . . . 0.88 111.549 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.72 -37.37 62.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.203 -0.453 . . . . 1.24 111.415 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.4 pp -75.9 -33.68 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.273 0.358 . . . . 1.3300000000000001 111.323 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.61 -35.01 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.486 0.491 . . . . 1.5800000000000001 111.232 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -78.8 -27.97 44.49 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.532 0.52 . . . . 2.0600000000000001 111.506 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -86.41 -19.87 29.04 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.39 0.431 . . . . 1.28 111.593 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.5 ttt180 -92.98 -31.64 14.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.332 0.395 . . . . 1.78 110.909 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -89.78 -41.36 11.91 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.418 0.448 . . . . 1.5 111.361 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 . . . . . 0 N--CA 1.465 0.312 0 O-C-N 123.376 0.423 . . . . 1.3100000000000001 110.992 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.629 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.463 -0.255 . . . . 2.3500000000000001 112.463 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.4 tp -62.92 -37.22 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 122.958 0.503 . . . . 2.4500000000000002 111.743 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.73 -28.94 66.18 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.148 -0.478 . . . . 1.23 112.896 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.17 -43.29 43.38 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.581 0.352 . . . . 1.3700000000000001 111.179 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.2 m -73.74 -22.7 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.403 -0.362 . . . . 1.28 111.666 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 9.2 tp -84.42 -39.95 18.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.121 -0.49 . . . . 1.1299999999999999 111.325 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -84.69 -11.42 55.9 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.844 0.683 . . . . 1.5900000000000001 112.844 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.42 -36.05 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 122.903 0.127 . . . . 1.0900000000000001 111.331 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 5.2 mt -107.15 -34.4 7.15 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.59 0.589 . . . . 1.1899999999999999 112.59 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.573 ' OG1' ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -93.0 36.22 1.04 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 120.968 0.413 . . . . 1.05 111.382 -179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -140.05 -46.11 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.976 -0.556 . . . . 1.51 111.487 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.66 94.51 0.82 Allowed Glycine 0 C--N 1.338 0.689 0 O-C-N 123.541 0.525 . . . . 0.97999999999999998 112.541 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' O ' HG12 ' A' ' 17' ' ' ILE . 1.3 mp -105.99 -46.86 0.13 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 118.673 -0.679 . . . . 1.5 112.306 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.28 -12.07 31.25 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.275 1.983 . . . . 0.92000000000000004 113.779 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' O ' ' HD1' ' A' ' 19' ' ' TRP . . . -72.72 -40.73 65.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.457 0.303 . . . . 0.88 111.472 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.43 -34.82 68.1 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.173 -0.467 . . . . 1.23 110.908 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -69.91 -35.77 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.793 -0.64 . . . . 0.64000000000000001 109.99 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.4 m -74.62 -30.39 61.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.659 -0.7 . . . . 0.88 111.251 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.401 ' HD1' ' O ' ' A' ' 15' ' ' ALA . 15.1 m95 -74.6 -37.81 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.286 -0.416 . . . . 1.24 111.23 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.1 pp -76.03 -30.89 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 116.341 -0.39 . . . . 1.3300000000000001 111.134 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -76.36 -32.57 58.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.011 -0.54 . . . . 1.5800000000000001 111.058 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.9 mtt180 -80.97 -26.38 36.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.174 -0.467 . . . . 2.0600000000000001 111.096 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -85.26 -23.87 28.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.094 -0.503 . . . . 1.28 111.232 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.1 ttt180 -91.06 -31.26 16.34 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.534 0.521 . . . . 1.78 111.304 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.39 -44.44 9.65 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.257 0.348 . . . . 1.5 111.358 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 53.5 mt-30 -100.03 -50.49 3.97 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.396 0.435 . . . . 1.3100000000000001 111.075 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.134 0 CA-C-N 116.067 -0.515 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.437 -0.265 . . . . 2.3500000000000001 112.437 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.527 ' H ' HD12 ' A' ' 2' ' ' ILE . 1.2 mp -65.35 -40.41 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.836 0.454 . . . . 2.4500000000000002 111.1 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.0 -33.81 70.29 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.486 0.491 . . . . 1.23 113.236 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.531 ' O ' HG23 ' A' ' 8' ' ' VAL . . . -72.87 -48.76 34.71 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.588 0.355 . . . . 1.3700000000000001 111.37 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 1' ' ' GLY . 25.2 t -66.73 -28.46 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.485 -0.325 . . . . 1.28 110.517 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 7.9 tp -76.06 -39.43 55.48 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.364 -0.38 . . . . 1.1299999999999999 111.2 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -74.91 -22.86 58.36 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.217 0.451 . . . . 1.5900000000000001 112.217 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 4' ' ' ALA . 48.4 t -91.4 -21.84 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 110.079 -0.341 . . . . 1.0900000000000001 110.079 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.6 mp -93.67 -11.31 31.89 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.133 0.42 . . . . 1.1899999999999999 112.133 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 p -90.21 -29.58 18.12 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.146 0.424 . . . . 1.05 112.146 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -90.9 -46.73 8.01 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.222 0.326 . . . . 1.51 111.732 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.15 97.35 1.74 Allowed Glycine 0 C--N 1.339 0.696 0 O-C-N 123.421 0.451 . . . . 0.97999999999999998 112.557 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -125.34 -48.58 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 118.7 -0.667 . . . . 1.5 111.647 179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.4 Cg_exo -78.98 -5.62 14.64 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.395 2.064 . . . . 0.92000000000000004 113.325 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.61 67.94 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 122.712 0.405 . . . . 0.88 111.911 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tp -72.76 -35.42 67.47 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 1.23 110.951 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 mm -71.01 -36.7 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.856 -0.611 . . . . 0.64000000000000001 110.14 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -74.6 -29.81 61.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.85 -0.614 . . . . 0.88 111.388 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -75.75 -36.91 59.74 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.421 0.45 . . . . 1.24 111.204 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -76.31 -31.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.301 -0.409 . . . . 1.3300000000000001 110.947 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -75.96 -34.16 59.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.937 -0.574 . . . . 1.5800000000000001 111.061 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 73.5 mtt180 -80.17 -25.62 39.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.173 -0.467 . . . . 2.0600000000000001 111.272 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -85.63 -24.97 26.9 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.256 -0.429 . . . . 1.28 111.33 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.7 ttt180 -90.8 -30.43 17.0 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.463 0.477 . . . . 1.78 111.387 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -92.29 -43.53 9.23 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.271 0.357 . . . . 1.5 111.45 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.8 mt-30 -102.61 -50.45 3.56 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.407 0.442 . . . . 1.3100000000000001 111.016 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.096 -0.502 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.627 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 112.647 -0.181 . . . . 2.3500000000000001 112.647 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 mt -66.74 -44.03 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.944 0.498 . . . . 2.4500000000000002 110.875 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.17 -26.5 74.17 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.01 -0.541 . . . . 1.23 113.005 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.12 -44.92 28.68 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.604 0.362 . . . . 1.3700000000000001 111.112 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 1' ' ' GLY . 13.1 m -73.17 -21.72 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 123.263 0.352 . . . . 1.28 111.491 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tt -85.74 -32.6 21.78 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.165 -0.47 . . . . 1.1299999999999999 110.772 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -84.87 -15.17 45.55 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.129 -0.487 . . . . 1.5900000000000001 112.273 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.16 -36.79 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 O-C-N 122.975 0.172 . . . . 1.0900000000000001 111.06 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 6.3 mp -96.41 -40.35 9.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.78 0.289 . . . . 1.1899999999999999 111.78 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -95.59 73.07 3.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.41 0.624 . . . . 1.05 110.685 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -149.76 -46.17 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.239 -0.891 . . . . 1.51 110.898 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.8 101.77 0.37 Allowed Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.989 -0.55 . . . . 0.97999999999999998 112.236 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.6 mp -94.95 -38.59 0.29 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.608 -0.711 . . . . 1.5 112.728 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.25 -13.09 38.35 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.214 1.942 . . . . 0.92000000000000004 113.886 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.06 -42.5 63.02 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.26 0.35 . . . . 0.88 111.604 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.7 -33.64 64.48 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.274 -0.421 . . . . 1.23 111.388 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 13' ' ' LEU . 11.5 mm -70.91 -38.58 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 123.518 0.511 . . . . 0.64000000000000001 110.108 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.5 m -73.94 -30.22 62.44 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.873 -0.603 . . . . 0.88 111.409 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -75.16 -37.34 61.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.22 -0.446 . . . . 1.24 111.259 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.85 -31.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 116.426 -0.352 . . . . 1.3300000000000001 111.049 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -76.4 -32.63 58.65 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.006 -0.543 . . . . 1.5800000000000001 111.115 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 97.4 mtt180 -80.97 -26.01 36.9 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.139 -0.482 . . . . 2.0600000000000001 111.221 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -86.5 -23.91 25.75 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.43 0.456 . . . . 1.28 111.356 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 25.0 ttt180 -90.4 -33.26 16.1 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.449 0.468 . . . . 1.78 111.117 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -89.29 -42.12 11.78 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.368 0.417 . . . . 1.5 111.421 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.5 mt-30 -105.19 -50.6 3.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.929 0.395 . . . . 1.3100000000000001 111.052 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.102 -0.499 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.5 -0.24 . . . . 2.3500000000000001 112.5 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.2 tp -60.81 -36.29 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.092 0.557 . . . . 2.4500000000000002 111.861 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -71.22 -32.74 65.22 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.984 -0.553 . . . . 1.23 113.437 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.57 -45.81 28.87 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.493 0.317 . . . . 1.3700000000000001 111.38 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.7 m -65.17 -37.09 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 116.317 -0.401 . . . . 1.28 111.355 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.81 -38.17 64.68 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.763 -0.653 . . . . 1.1299999999999999 111.157 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 27.1 tttp -74.54 -11.66 60.27 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.284 0.365 . . . . 1.5900000000000001 111.747 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 p -110.46 -7.19 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.202 0.314 . . . . 1.0900000000000001 111.552 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -107.6 -41.39 5.05 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.579 0.585 . . . . 1.1899999999999999 112.579 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 43.3 p -84.78 1.07 48.4 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.573 0.583 . . . . 1.05 112.573 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.9 p -95.47 -44.52 7.49 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.667 -0.242 . . . . 1.51 111.57 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.63 115.6 3.55 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 123.457 0.473 . . . . 0.97999999999999998 112.604 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.512 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 4.1 mp -128.98 -45.81 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.619 -0.705 . . . . 1.5 112.187 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.512 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 8.3 Cg_exo -73.34 -7.13 19.99 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.312 2.008 . . . . 0.92000000000000004 113.284 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.53 59.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.663 0.385 . . . . 0.88 111.675 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.8 -33.09 60.1 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.182 -0.463 . . . . 1.23 111.103 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 13' ' ' LEU . 7.9 mm -71.91 -40.75 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.914 -0.585 . . . . 0.64000000000000001 110.086 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.1 m -74.13 -26.63 60.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.812 -0.631 . . . . 0.88 111.075 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m95 -76.08 -37.71 57.87 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.032 -0.531 . . . . 1.24 111.194 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 17' ' ' ILE . 2.3 pp -77.1 -31.35 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.369 0.418 . . . . 1.3300000000000001 111.131 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.89 -34.31 59.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.932 -0.576 . . . . 1.5800000000000001 111.032 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.95 -24.61 38.0 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.967 -0.561 . . . . 2.0600000000000001 111.295 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 29.0 tttm -86.55 -23.63 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.459 0.474 . . . . 1.28 110.913 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -90.7 -33.81 15.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.109 -0.496 . . . . 1.78 111.39 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -89.37 -42.56 11.47 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.418 0.448 . . . . 1.5 111.638 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 55.2 mt-30 -104.64 -50.16 3.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.968 0.413 . . . . 1.3100000000000001 111.075 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.121 -0.49 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.598 -0.201 . . . . 2.3500000000000001 112.598 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp -62.27 -39.53 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.992 0.517 . . . . 2.4500000000000002 112.327 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -70.41 -31.38 68.5 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.015 -0.538 . . . . 1.23 113.076 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.622 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -74.97 -45.73 40.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 122.648 0.379 . . . . 1.3700000000000001 111.354 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.3 m -65.85 -38.62 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 123.392 0.433 . . . . 1.28 111.484 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 2' ' ' ILE . 12.9 mt -73.22 -30.17 63.31 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.984 -0.553 . . . . 1.1299999999999999 111.179 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -71.93 -36.28 69.9 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.487 0.492 . . . . 1.5900000000000001 111.5 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 4' ' ' ALA . 7.9 m -87.45 -15.61 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 123.376 0.423 . . . . 1.0900000000000001 112.089 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -92.94 -23.2 18.81 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.325 0.391 . . . . 1.1899999999999999 112.019 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.0 p -87.44 -1.05 57.66 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.36 0.504 . . . . 1.05 112.36 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -110.6 -46.16 3.42 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.914 0.338 . . . . 1.51 111.914 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.64 110.62 4.07 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 121.408 -0.425 . . . . 0.97999999999999998 112.886 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.531 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 1.8 tp -138.72 -46.78 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.735 -0.65 . . . . 1.5 111.922 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.5 Cg_exo -78.87 -10.55 15.43 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.449 2.099 . . . . 0.92000000000000004 113.661 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.49 -42.55 67.91 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.647 0.379 . . . . 0.88 111.998 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.99 -35.55 69.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.404 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.2 mm -70.4 -38.69 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 123.599 0.562 . . . . 0.64000000000000001 110.468 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.1 m -72.75 -32.36 65.6 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.952 -0.567 . . . . 0.88 111.398 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -73.9 -38.05 64.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.186 -0.461 . . . . 1.24 111.519 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.28 -34.04 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.274 0.359 . . . . 1.3300000000000001 111.481 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -74.53 -35.43 63.15 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.195 -0.457 . . . . 1.5800000000000001 111.413 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 94.4 mtt180 -78.54 -28.53 46.08 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.153 -0.476 . . . . 2.0600000000000001 111.489 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -85.47 -20.53 29.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.361 -0.382 . . . . 1.28 111.666 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 31.3 ttt180 -92.43 -31.13 15.4 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.38 0.425 . . . . 1.78 110.989 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.38 -41.37 12.16 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.427 0.454 . . . . 1.5 111.398 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 52.7 mt-30 -106.37 -49.6 3.31 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.43 0.456 . . . . 1.3100000000000001 111.075 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.092 -0.504 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.471 -0.252 . . . . 2.3500000000000001 112.471 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp -63.11 -40.08 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 122.796 0.438 . . . . 2.4500000000000002 112.069 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.441 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -70.49 -32.43 67.9 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.961 -0.563 . . . . 1.23 113.032 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -72.55 -47.32 49.19 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.528 0.331 . . . . 1.3700000000000001 111.23 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 1' ' ' GLY . 5.9 m -66.2 -36.02 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 123.365 0.416 . . . . 1.28 111.598 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.71 -32.49 65.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.126 -0.488 . . . . 1.1299999999999999 111.456 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.6 -33.23 64.5 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.439 0.462 . . . . 1.5900000000000001 111.853 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 4' ' ' ALA . 8.4 m -90.48 -9.75 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.004 0.372 . . . . 1.0900000000000001 112.004 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 5.3 tp -99.26 -26.8 14.05 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.22 0.325 . . . . 1.1899999999999999 111.701 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p -84.45 -7.01 59.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.383 0.512 . . . . 1.05 112.383 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -102.94 -45.86 4.84 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.149 0.28 . . . . 1.51 111.729 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.35 108.14 3.56 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 121.38 -0.438 . . . . 0.97999999999999998 112.862 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.5 tp -136.38 -46.63 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 CA-C-O 118.768 -0.634 . . . . 1.5 111.782 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.6 Cg_exo -78.89 -10.77 15.36 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.518 2.146 . . . . 0.92000000000000004 113.64 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.35 -41.7 66.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.906 0.336 . . . . 0.88 111.906 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -71.52 -35.63 70.78 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.324 -0.398 . . . . 1.23 111.255 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.3 mm -70.92 -39.5 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.836 -0.62 . . . . 0.64000000000000001 110.614 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -72.86 -31.25 64.62 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.041 -0.527 . . . . 0.88 111.51 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.83 -37.58 62.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.127 -0.488 . . . . 1.24 111.398 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.51 -33.55 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 123.294 0.371 . . . . 1.3300000000000001 111.315 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -74.92 -34.92 62.19 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.503 0.502 . . . . 1.5800000000000001 111.339 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -78.78 -28.39 44.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.079 -0.51 . . . . 2.0600000000000001 111.439 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -85.99 -19.28 30.61 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.328 0.392 . . . . 1.28 111.665 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 36.1 ttt180 -93.34 -31.68 14.58 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.349 0.406 . . . . 1.78 110.915 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -89.39 -40.96 12.39 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.422 0.452 . . . . 1.5 111.388 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -109.47 -50.63 2.97 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.41 0.444 . . . . 1.3100000000000001 111.061 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.084 -0.507 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.602 -0.199 . . . . 2.3500000000000001 112.602 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.0 pp -60.59 -37.92 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 112.378 0.51 . . . . 2.4500000000000002 112.378 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.47 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -70.26 -35.26 69.77 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.021 -0.536 . . . . 1.23 113.027 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -71.86 -46.42 58.0 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 122.564 0.346 . . . . 1.3700000000000001 111.379 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 1' ' ' GLY . 3.9 m -66.12 -36.7 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 123.379 0.425 . . . . 1.28 111.627 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.3 -32.44 66.58 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.474 0.484 . . . . 1.1299999999999999 111.407 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -73.9 -33.24 63.93 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.398 0.436 . . . . 1.5900000000000001 111.999 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 4' ' ' ALA . 9.2 m -89.71 -11.09 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.024 0.379 . . . . 1.0900000000000001 112.024 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.7 tp -97.82 -27.8 14.15 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.266 0.353 . . . . 1.1899999999999999 111.715 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 p -84.16 -10.84 57.43 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.575 0.584 . . . . 1.05 112.575 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 p -99.14 -45.46 5.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.246 0.341 . . . . 1.51 111.748 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.23 107.5 3.41 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 123.453 0.471 . . . . 0.97999999999999998 112.788 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.538 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 tp -136.04 -46.54 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.733 -0.651 . . . . 1.5 111.773 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.0 Cg_exo -78.95 -11.44 15.06 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.437 2.091 . . . . 0.92000000000000004 113.66 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.55 69.52 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.004 0.372 . . . . 0.88 112.004 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -72.28 -36.26 68.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.291 -0.413 . . . . 1.23 111.298 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 13' ' ' LEU . 9.0 mm -70.47 -38.92 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 123.624 0.578 . . . . 0.64000000000000001 110.541 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.0 m -73.0 -31.89 64.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.991 -0.55 . . . . 0.88 111.482 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -74.58 -37.26 62.96 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.134 -0.485 . . . . 1.24 111.492 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -75.73 -33.6 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 123.3 0.375 . . . . 1.3300000000000001 111.309 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.84 -34.58 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.51 0.506 . . . . 1.5800000000000001 111.324 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.83 -28.65 44.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 2.0600000000000001 111.379 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -86.01 -18.82 31.5 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.411 0.444 . . . . 1.28 111.741 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.9 ttt180 -93.64 -32.0 14.25 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.35 0.406 . . . . 1.78 110.896 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.13 -41.58 12.19 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.168 -0.469 . . . . 1.5 111.426 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -109.16 -50.37 3.01 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.418 0.449 . . . . 1.3100000000000001 111.07 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.081 -0.509 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.621 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.541 -0.224 . . . . 2.3500000000000001 112.541 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.2 pp -62.11 -37.08 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 122.935 0.494 . . . . 2.4500000000000002 112.283 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -71.18 -31.9 66.01 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.952 -0.567 . . . . 1.23 113.108 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.02 -45.1 36.22 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 122.58 0.352 . . . . 1.3700000000000001 111.597 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 1' ' ' GLY . 5.2 m -69.71 -34.19 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 123.31 0.382 . . . . 1.28 111.882 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tt -75.7 -41.52 53.4 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.132 -0.485 . . . . 1.1299999999999999 111.065 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.8 tttp -73.76 -17.94 61.04 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.19 0.441 . . . . 1.5900000000000001 112.19 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 5' ' ' VAL . 5.4 p -97.57 -23.37 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 O-C-N 123.246 0.341 . . . . 1.0900000000000001 111.519 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -89.59 -39.11 13.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.322 0.49 . . . . 1.1899999999999999 112.322 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.5 p -87.76 53.32 2.73 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.425 0.631 . . . . 1.05 111.318 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.7 p -141.53 -45.16 0.36 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.413 -0.812 . . . . 1.51 111.014 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.75 87.5 0.32 Allowed Glycine 0 C--N 1.34 0.771 0 O-C-N 123.52 0.512 . . . . 0.97999999999999998 112.209 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.15 -44.74 0.35 Allowed Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 118.69 -0.672 . . . . 1.5 112.167 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.35 -3.12 12.79 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.284 1.99 . . . . 0.92000000000000004 113.554 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' TRP . . . -74.29 -39.29 63.04 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.617 0.367 . . . . 0.88 111.661 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.87 -34.09 57.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.111 -0.495 . . . . 1.23 111.194 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 mm -70.88 -40.58 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 116.068 -0.514 . . . . 0.64000000000000001 110.056 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.6 m -74.35 -26.02 59.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.745 -0.661 . . . . 0.88 111.087 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -76.07 -38.11 57.44 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.972 -0.558 . . . . 1.24 111.086 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.3 pp -77.02 -31.07 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.274 -0.421 . . . . 1.3300000000000001 111.022 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -75.85 -34.04 60.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.981 -0.554 . . . . 1.5800000000000001 111.022 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 80.3 mtt180 -80.48 -26.79 38.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.062 -0.517 . . . . 2.0600000000000001 111.272 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 19' ' ' TRP . 31.7 tttm -85.98 -20.49 28.83 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.485 0.491 . . . . 1.28 111.041 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 26.9 ttt180 -94.33 -31.02 14.22 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.36 0.412 . . . . 1.78 111.034 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -90.64 -43.56 10.08 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.327 0.392 . . . . 1.5 111.543 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.7 mt-30 -99.44 -50.59 4.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 1.3100000000000001 111.146 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 116.094 -0.503 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 112.765 -0.134 . . . . 2.3500000000000001 112.765 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pt -62.92 -42.11 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.027 0.531 . . . . 2.4500000000000002 112.154 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 7' ' ' LYS . . . -70.61 -28.06 71.57 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.84 -0.618 . . . . 1.23 113.23 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.38 -43.7 31.86 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.581 0.352 . . . . 1.3700000000000001 111.383 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 1' ' ' GLY . 8.6 m -73.18 -24.35 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 116.491 -0.322 . . . . 1.28 111.642 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.448 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 4.0 tp -84.34 -39.1 19.53 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.222 -0.445 . . . . 1.1299999999999999 111.282 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 2.5 tptp -81.21 -18.51 45.89 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.817 0.673 . . . . 1.5900000000000001 112.817 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.7 t -106.46 -42.75 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 122.961 0.163 . . . . 1.0900000000000001 111.387 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.44 -35.29 13.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.261 0.467 . . . . 1.1899999999999999 112.261 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -95.71 64.18 2.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.456 0.646 . . . . 1.05 110.656 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.9 p -145.55 -45.05 0.21 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.176 -0.92 . . . . 1.51 110.991 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.39 112.5 1.36 Allowed Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.019 -0.537 . . . . 0.97999999999999998 112.305 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 17' ' ' ILE . 3.1 mp -103.67 -44.7 0.18 Allowed Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 118.628 -0.701 . . . . 1.5 112.489 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.94 -7.71 19.42 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.396 2.064 . . . . 0.92000000000000004 114.162 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.67 -42.19 61.67 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.483 0.313 . . . . 0.88 111.521 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.33 -34.21 63.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.083 -0.508 . . . . 1.23 111.048 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 13' ' ' LEU . 6.4 mm -69.99 -38.24 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.868 -0.606 . . . . 0.64000000000000001 109.984 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.8 m -74.47 -27.79 60.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.757 -0.656 . . . . 0.88 111.242 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -75.22 -38.48 60.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 1.24 111.202 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.2 pp -76.45 -31.16 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.192 -0.458 . . . . 1.3300000000000001 111.103 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -75.85 -33.18 60.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.939 -0.573 . . . . 1.5800000000000001 111.113 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 26' ' ' GLN . 92.5 mtt180 -80.69 -26.28 37.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.038 -0.528 . . . . 2.0600000000000001 111.077 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.1 mttm -85.78 -21.63 28.09 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.065 -0.516 . . . . 1.28 111.413 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 24.9 ttt180 -93.75 -32.77 13.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.145 -0.48 . . . . 1.78 111.209 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.28 -43.55 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.349 0.405 . . . . 1.5 111.508 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 54.6 mt-30 -102.26 -50.52 3.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.007 0.432 . . . . 1.3100000000000001 111.131 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 116.102 -0.499 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.621 ' O ' HG22 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.478 -0.249 . . . . 2.3500000000000001 112.478 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 3' ' ' GLY . 2.1 pp -63.45 -37.69 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.407 0.521 . . . . 2.4500000000000002 112.407 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' N ' HD12 ' A' ' 2' ' ' ILE . . . -70.82 -32.23 66.83 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 116.012 -0.54 . . . . 1.23 112.873 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 8' ' ' VAL . . . -74.77 -47.66 29.73 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.575 0.35 . . . . 1.3700000000000001 111.367 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 1' ' ' GLY . 4.6 m -65.12 -36.58 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.324 0.39 . . . . 1.28 111.447 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 2' ' ' ILE . 9.0 mt -74.13 -29.55 61.87 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.157 -0.474 . . . . 1.1299999999999999 111.142 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -72.66 -34.24 67.11 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.442 0.464 . . . . 1.5900000000000001 111.569 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 4' ' ' ALA . 5.6 m -91.25 -9.97 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.115 0.413 . . . . 1.0900000000000001 112.115 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.2 tp -97.78 -27.28 14.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.225 0.328 . . . . 1.1899999999999999 111.686 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.3 p -85.17 -6.45 59.28 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.432 0.53 . . . . 1.05 112.432 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.6 p -103.49 -45.88 4.72 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.798 0.296 . . . . 1.51 111.798 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.19 109.81 3.85 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 121.374 -0.441 . . . . 0.97999999999999998 112.913 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.538 ' H ' ' CD ' ' A' ' 14' ' ' PRO . 2.1 tp -136.55 -46.56 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.811 -0.614 . . . . 1.5 111.845 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' CD ' ' H ' ' A' ' 13' ' ' LEU . 4.3 Cg_exo -78.99 -10.41 15.3 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.437 2.091 . . . . 0.92000000000000004 113.743 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -41.85 67.28 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.022 0.378 . . . . 0.88 112.022 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.01 -35.69 69.51 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.331 -0.395 . . . . 1.23 111.355 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 13' ' ' LEU . 8.4 mm -70.56 -39.53 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 123.658 0.599 . . . . 0.64000000000000001 110.463 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -72.56 -31.5 65.3 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.025 -0.534 . . . . 0.88 111.549 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -74.72 -37.37 62.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.203 -0.453 . . . . 1.24 111.415 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 2.4 pp -75.9 -33.68 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 123.273 0.358 . . . . 1.3300000000000001 111.323 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -74.61 -35.01 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.486 0.491 . . . . 1.5800000000000001 111.232 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -78.8 -27.97 44.49 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.532 0.52 . . . . 2.0600000000000001 111.506 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -86.41 -19.87 29.04 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.39 0.431 . . . . 1.28 111.593 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 34.5 ttt180 -92.98 -31.64 14.82 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.332 0.395 . . . . 1.78 110.909 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -89.78 -41.36 11.91 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.418 0.448 . . . . 1.5 111.361 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -108.81 -50.71 2.98 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.376 0.423 . . . . 1.3100000000000001 110.992 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.126 -0.488 . . . . 0.83999999999999997 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' 3UQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_